Pmjay Himcare Oncology

SL# Package Package PackageName PackageDescription PackageId- PackageID- IsMedSur Amount PreAuthS Government_
Category Category PMJAY HIMCARE gical tatus Reserved

Code Code
514 MO MO001 CT for CA Breast Cyclophosphamide + MO001A MO001A1 S 8100 Y N
EpirubcinCyclophosphamid
e - 600 mg /m2
D1Epirubicin -90mg/m2 D1
every 21 days
515 MO MO001 CT for CA Breast Cyclophosphamide + MO001A MO001A2 S 7200 Y N

Epirubcin
Cyclophosphamide - 830
mg /m2 D1 Epirubicin -
100mg/m2 D1 every 21
days
516 MO MO001 CT for CA Breast Weekly Paclitaxel for MO001B MO001B1 S 5800 Y N
Adjuvant Therapy
Paclitaxel 80mg/m2 every
week
517 MO MO001 CT for CA Breast Weekly Paclitaxel in MO001C MO001C1 S 5800 Y N
metastatic setting
Paclitaxel 80mg/m2 every
week
518 MO MO001 CT for CA Breast Cyclophosphamide + MO001D MO001D1 S 3200 Y N
Methotrexate + 5 - FU
Cyclophosphamide -
100mg/m2 orally D1-D14
Methotrexate 40mg/m2 IV
D1 D8 5FU 600 mg/m2 D1,
D8 every 28 days
519 MO MO001 CT for CA Breast Cyclophosphamide + MO001D MO001D2 S 3900 Y N

Methotrexate + 5 -
FUCyclophosphamide -
100mg/m2 orally D1-D14
Methotrexate 40mg/m2 IV
D1D8 5FU 600 mg/m2 D1,
D8 every 28 days
520 MO MO001 CT for CA Breast Docetaxel + MO001E MO001E1 S 19800 Y N

Cyclophosphamide
Docetaxel 75mg/m2 D1
Cyclophosphamide 600
mg/m2 D1 every 21 days
521 MO MO001 CT for CA Breast Docetaxel + MO001E MO001E2 S 10200 Y N

CyclophosphamideDocetax
el 75mg/m2
D1Cyclophosphamide 600
mg/m2 D1 every 21 days
522 MO MO001 CT for CA Breast Trastuzumab Trastuzumab MO001F MO001F1 S 21200 Y N 2D ECHO,2D-ECHO,Biopsy/ Barcode of the drug,BAR
8 mg/Kg in Cycle 1 D1 pathology report of Modified CODE OF THE
Trastuzumab 6 mg/kg D1 radical mastectomy or breast DRUGS,CHARTS OF
from C2 every 21 days conservation surgery,Biopsy CHEMOTHERAPY
report or surgical pathology REGIMEN,Charts of
report of Modified radical Chemotherapy regimen &
mastectomy or breast transfusion slips,Clinical
conservation surgery,Blood notes,Details of Follow-up
investigation (CBC, and Supportive care that may
LFT,RFT),CBC,Clinical be required & indications for
it eg. for Neutropenia, Growth
facto
523 MO MO001 CT for CA Breast TrastuzumabTrastuzumab 8 MO001F MO001F2 S 23400 Y N 2D ECHO,2D-ECHO,Biopsy/ Barcode of the drug,BAR
mg/Kg in Cycle 1 pathology report of Modified CODE OF THE
D1Trastuzumab 6 mg/kg D1 radical mastectomy or breast DRUGS,CHARTS OF
from C2 every 21 days conservation surgery,Biopsy CHEMOTHERAPY
facto
524 MO MO001 CT for CA Breast TamoxifenTamoxifem 20 MO001G MO001G1 S 1300 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
mg orally daily report of Modified radical CODE OF THE
mastectomy or breast DRUGS,CHARTS OF
conservation surgery,Biopsy CHEMOTHERAPY
LFT,RFT),CBC,Clinical notes be required & indications for
/ it eg. for Neutropenia, Growth
facto
525 MO MO001 CT for CA Breast Letrozole Letrozole 2.5 mg MO001H MO001H1 S 4300 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
orally daily report of Modified radical CODE OF THE
facto
526 MO MO001 CT for CA Breast Carboplatin + Paclitaxel MO001I MO001I1 S 16400 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
Paclitaxel 175mg/m2 report of Modified radical CODE OF THE
D1Carboplatin AUC 5-6 D1 mastectomy or breast DRUGS,CHARTS OF
every 21 days conservation surgery,Biopsy CHEMOTHERAPY
facto
527 MO MO001 CT for CA Breast Capecitabine Capecitabine - MO001J MO001J1 S 7400 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
1000mg/m2 orally twice report of Modified radical CODE OF THE
daily D1-D14 every 21 days mastectomy or breast DRUGS,CHARTS OF
facto
528 MO MO001 CT for CA Breast CapecitabineCapecitabine - MO001J MO001J2 S 8200 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
1000mg/m2 orally twice report of Modified radical CODE OF THE
daily D1-D14 every 21 days mastectomy or breast DRUGS,CHARTS OF
facto
529 MO MO001 CT for CA Breast Carboplatin + Gemcitabine MO001K MO001K1 S 13900 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
Gemcitabine - 1000mg/m2 report of Modified radical CODE OF THE
D1 D8 Carboplatin AUC 2 mastectomy or breast DRUGS,CHARTS OF
D1 D8 Gemcitabine - conservation surgery,Biopsy CHEMOTHERAPY
1000mg/m2 D1 D8 report or surgical pathology REGIMEN,Charts of
Carboplatin AUC 5-6 D1 report of Modified radical Chemotherapy regimen &
only mastectomy or breast transfusion slips,Clinical
facto
530 MO MO001 CT for CA Breast Carboplatin + MO001K MO001K2 S 15300 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
GemcitabineGemcitabine - report of Modified radical CODE OF THE
1000mg/m2 D1 mastectomy or breast DRUGS,CHARTS OF
D8Carboplatin AUC 2 D1 conservation surgery,Biopsy CHEMOTHERAPY
D8Gemcitabine - report or surgical pathology REGIMEN,Charts of
1000mg/m2 D1 D8 report of Modified radical Chemotherapy regimen &
Carboplatin AUC 5-6 D1 mastectomy or breast transfusion slips,Clinical
only conservation surgery,Blood notes,Details of Follow-up
facto
531 MO MO001 CT for CA Breast Cyclophosphamide + MO001L MO001L1 S 4500 Y N 2D ECHO,2D-ECHO,Biopsy/ Barcode of the drug,BAR
Adriamycin pathology report of Modified CODE OF THE
Cyclophosphamide - 600 radical mastectomy or breast DRUGS,CHARTS OF
mg /m2 D1 Adriamycin - conservation surgery,Biopsy CHEMOTHERAPY
60mg/m2 D1 every 21 days report or surgical pathology REGIMEN,Charts of
facto
532 MO MO001 CT for CA Breast Cyclophosphamide + MO001L MO001L2 S 5000 Y N 2D ECHO,2D-ECHO,Biopsy/ Barcode of the drug,BAR
AdriamycinCyclophosphami pathology report of Modified CODE OF THE
de - 600 mg /m2 radical mastectomy or breast DRUGS,CHARTS OF
D1Adriamycin - 60mg/m2 conservation surgery,Biopsy CHEMOTHERAPY
D1 every 21 days report or surgical pathology REGIMEN,Charts of
facto
533 MO MO001 CT for CA Breast Fulvestrant Fulvestrant 500 MO001M MO001M1 S 11000 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
mg D1 D15 D28 then every report of Modified radical CODE OF THE
28 days mastectomy or breast DRUGS,CHARTS OF
facto
534 MO MO001 CT for CA Breast FulvestrantFulvestrant 500 MO001M MO001M2 S 13200 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
mg D1 D15 D28 then every report of Modified radical CODE OF THE
28 days.per dose13200 mastectomy or breast DRUGS,CHARTS OF
(39600 in cycle1 ) then conservation surgery,Biopsy CHEMOTHERAPY
13200 per month report or surgical pathology REGIMEN,Charts of
facto
535 MO MO001 CT for CA Breast Paclitaxel Paclitaxel 175 MO001N MO001N1 S 13000 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
mg/m2 D1 every 21 days report of Modified radical CODE OF THE
facto
536 MO MO001 CT for CA Breast Exemestane Exemestane MO001O MO001O1 S 10400 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
25 mg orally daily report of Modified radical CODE OF THE
facto
537 MO MO001 CT for CA Breast Exemestane Exemestane MO001O MO001O2 S 4300 Y N 2D ECHO,Biopsy/ pathology Barcode of the drug,BAR
25 mg orally daily (q 3 report of Modified radical CODE OF THE
monthsly) mastectomy or breast DRUGS,CHARTS OF
facto
538 MO MO002 CT for Metastatic bone Zoledronic Acid Zoledronic MO002A MO002A1 S 3900 Y N Blood Investigations such as Bar code of the drugs,BAR
malignancy and multiple acid 4 mg IV Monthly CBC, LFT, RFT, Ca, Viral CODE OF THE
myeloma markers (HBsAg, HCV, HIV), DRUGS,CHARTS OF
calculated creatinine CHEMOTHERAPY
clearance, Beta2 REGIMEN,Charts of
microglobulin, SPEP+IFE, chemotherapy regimen,
S.FLC assay, Urine Bence transfusion
Jones Protein (BJP) ( may slips,DISCHARGE
not be done if SPEP and FLC SUMMARY OF INPATIENT
assay show M band or DEPARTMENT /
abnormal f DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
539 MO MO003 CT for CA Ovary Cisplatin + Irinotecan MO003A MO003A1 S 14400 Y N Admission/clinical notes with Bar code of the drugs ,BAR
Cisplatin 60mg/m2 planned line of CODE OF THE
D1Irinotecan 60 mg/m2 D1 treatment,Biochemistry DRUGS,Charts of
D8 D15 every 28 days reports (LFT, RFT and chemotherapy
RBS),CA-125,CA-125 regimen,CHARTS OF
,CBC,CBC ,CECT Thorax, CHEMOTHERAPY
abdomen and Pelvis,Chest X- REGIMEN,DISCHARGE
ray/ CECT Thorax ,HPE or SUMMARY OF INPATIENT
cytology suggestive of DEPARTMENT /
ovarian DISCHARGE SUMMARY
adenocarcinoma,LFT,RBS,R OF DAY CARE
FT,USG/ CT/ MRI DEPARTMENT,Reports of
the tests (pathology,
radiology, microbiology,
hemat
540 MO MO003 CT for CA Ovary Lipodox + Carboplatin MO003B MO003B1 S 19000 Y N Admission/clinical notes with Bar code of the drugs ,BAR
Lipopdox 30 mg/m2 D1 planned line of CODE OF THE
Carboplatin AUC 5-6 D1 treatment,Biochemistry DRUGS,Charts of
every 28 days reports (LFT, RFT and chemotherapy
hemat
541 MO MO003 CT for CA Ovary Etoposide Etoposide 50 MO003C MO003C1 S 3400 Y N Admission/clinical notes with Bar code of the drugs ,BAR
mg/m2 OD D1-D14 every planned line of CODE OF THE
21 days treatment,Biochemistry DRUGS,Charts of
reports (LFT, RFT and chemotherapy
hemat
542 MO MO003 CT for CA Ovary Etoposide 50 mg/m2 OD MO003C MO003C2 S 3800 Y N Admission/clinical notes with Bar code of the drugs ,BAR
D1-D21 every 28 days planned line of CODE OF THE
treatment,Biochemistry DRUGS,Charts of
hemat
543 MO MO003 CT for CA Ovary Irinotecan Irinotecan 60 -90 MO003D MO003D1 S 12100 Y N Admission/clinical notes with Bar code of the drugs ,BAR
mg/m2 D1 D8 every 21 planned line of CODE OF THE
days treatment,Biochemistry DRUGS,Charts of
hemat
544 MO MO003 CT for CA Ovary LipodoxLipodox 40 mg/m2 MO003E MO003E1 S 19800 Y N Admission/clinical notes with Bar code of the drugs ,BAR
IV every 28 days planned line of CODE OF THE
treatment,Biochemistry DRUGS,Charts of
hemat
545 MO MO003 CT for CA Ovary Carboplatin + MO003F MO003F1 S 15300 Y N Admission/clinical notes with Bar code of the drugs ,BAR
GemcitabineGemcitabine - planned line of CODE OF THE
1000mg/m2 D1 D8 treatment,Biochemistry DRUGS,Charts of
Carboplatin AUC 2 D1 reports (LFT, RFT and chemotherapy
D8Gemcitabine - RBS),CA-125,CA-125 regimen,CHARTS OF
1000mg/m2 D1 ,CBC,CBC ,CECT Thorax, CHEMOTHERAPY
D8Carboplatin AUC 5-6 D1 abdomen and Pelvis,Chest X- REGIMEN,DISCHARGE
only ray/ CECT Thorax ,HPE or SUMMARY OF INPATIENT
hemat
546 MO MO003 CT for CA Ovary Carboplatin + Paclitaxel MO003G MO003G1 S 16400 Y N Admission/clinical notes with Bar code of the drugs ,BAR
Paclitaxel 175mg/m2 D1 planned line of CODE OF THE
Carboplatin AUC 5-6 D1 treatment,Biochemistry DRUGS,Charts of
every 21 days reports (LFT, RFT and chemotherapy
hemat
547 MO MO003 CT for CA Ovary Cyclophosphamide 50 MO003H MO003H1 S 3100 Y N CA-125,CBC,CECT Thorax, BAR CODE OF THE
mg/m2 OD D1-D21 every abdomen and Pelvis,HPE or DRUGS,CHARTS OF
28 days cytology suggestive of CHEMOTHERAPY
ovarian REGIMEN,DISCHARGE
adenocarcinoma,LFT,RBS,R SUMMARY OF INPATIENT
FT DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.),TRA
NFUSION SLIPS
548 MO MO003 CT for CA Ovary TamoxifenTamoxifem 20 MO003I MO003I1 S 1400 Y N CA-125,CBC,CECT Thorax, BAR CODE OF THE
mg orally daily (3 months) abdomen and Pelvis,HPE or DRUGS,CHARTS OF
cytology suggestive of CHEMOTHERAPY
FT DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
549 MO MO003 CT for CA Ovary LetrozoleLetrozole 2.5 mg MO003J MO003J1 S 4300 Y N CA-125,CBC,CECT Thorax, BAR CODE OF THE
orally daily (3 months) abdomen and Pelvis,HPE or DRUGS,CHARTS OF
cytology suggestive of CHEMOTHERAPY
FT DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
550 MO MO004 CT for Germ Cell Tumor Carboplatin (AUC MO004A MO004A1 S 8100 Y N Admission/clinical notes with Bar code of the drugs ,BAR
7)Carboplatin AUC 7 every planned line of CODE OF THE
21 days treatment,AFP,Beta- DRUGS,Charts of
HCG,Biochemistry reports chemotherapy
(LFT, RFT and RBS),Blood regimen,CHARTS OF
Investigations: Beta HCG, CHEMOTHERAPY
AFP, LDH,CBC,CBC ,CECT REGIMEN,DISCHARGE
Thorax, abdomen and SUMMARY OF INPATIENT
Pelvis,CECT Thorax, DEPARTMENT /
abdomen and Pelvis DISCHARGE SUMMARY
,ECG,ECG ,Histopathology - OF DAY CARE
testi DEPARTMENT,Reports of
hemat
551 MO MO004 CT for Germ Cell Tumor Bleomycin + Etoposide + MO004B MO004B1 S 13600 Y N Admission/clinical notes with Bar code of the drugs ,BAR
CisplatinBleomycin 30 units planned line of CODE OF THE
D1 D8 D15Cisplatin 20 treatment,AFP,Beta- DRUGS,Charts of
mg/m2 IV D1-D5Etoposide HCG,Biochemistry reports chemotherapy
100mg/m2 D1-D5 every 21 (LFT, RFT and RBS),Blood regimen,CHARTS OF
days Investigations: Beta HCG, CHEMOTHERAPY
Ovari DEPARTMENT,Reports of
hemat
552 MO MO004 CT for Germ Cell Tumor Etoposide + MO004C MO004C1 S 12000 Y N Admission/clinical notes with Bar code of the drugs ,BAR
CisplatinCisplatin 20 mg/m2 planned line of CODE OF THE
IV D1-D5Etoposide treatment,AFP,Beta- DRUGS,Charts of
100mg/m2 D1-D5 every 21 HCG,Biochemistry reports chemotherapy
days (LFT, RFT and RBS),Blood regimen,CHARTS OF
hemat
553 MO MO004 CT for Germ Cell Tumor Gemcitabine + Oxaliplatin MO004D MO004D1 S 19300 Y N Admission/clinical notes with Bar code of the drugs ,BAR
Gemcitabine 1000mg/m2 planned line of CODE OF THE
D1 D8 Oxaiplatin treatment,AFP,Beta- DRUGS,Charts of
130mg/m2 D1 every 21 HCG,Biochemistry reports chemotherapy
days (LFT, RFT and RBS),Blood regimen,CHARTS OF
hemat
554 MO MO004 CT for Germ Cell Tumor Gemcitabine + MO004E MO004E1 S 19300 Y N Admission/clinical notes with Bar code of the drugs ,BAR
PaclitaxelGemcitabine planned line of CODE OF THE
1000mg/m2 D1 D8 treatment,AFP,Beta- DRUGS,Charts of
D15Paclitaxel 100 mg/m2 HCG,Biochemistry reports chemotherapy
D1 D8 D15 every 28 days (LFT, RFT and RBS),Blood regimen,CHARTS OF
hemat
555 MO MO004 CT for Germ Cell Tumor Vinblastin + Ifosfamide + MO004G MO004G1 S 15000 Y N Admission/clinical notes with Bar code of the drugs ,BAR
Cisplatin Vinblastine 0.11 planned line of CODE OF THE
mg/kg IV D1-D2Mesna treatment,AFP,Beta- DRUGS,Charts of
240mg/m2 0h 4h 8h D1- HCG,Biochemistry reports chemotherapy
D5Ifosfamide 1200mg/m2 (LFT, RFT and RBS),Blood regimen,CHARTS OF
D1-D5Cisplatin 20 mg/m2 Investigations: Beta HCG, CHEMOTHERAPY
D1-D5 every 21 days AFP, LDH,CBC,CBC ,CECT REGIMEN,DISCHARGE
hemat
556 MO MO005 CT for Gestational Etoposide + Methotrexate + MO005A MO005A1 S 13300 Y N Admission Or Clinical BAR CODE OF THE
Trophoblastic Neoplasia Dactinomycin- Notes,Beta- HCG,CBC,CECT DRUGS,CHARTS OF
Cyclophosphamide + Thorax, abdomen and CHEMOTHERAPY
VincristineEtoposide Pelvis,LFT,RBS,RFT REGIMEN,DISCHARGE
100mg/m2 IV D1 SUMMARY OF INPATIENT
D2Dactinomycin 0.5 mg IV DEPARTMENT /
push D1 D2Methotrexate DISCHARGE SUMMARY
300 mg /m2 D1Leucovorin OF DAY CARE
15 mg PO every 12 hrs for DEPARTMENT,REPORTS
4 dosesCyclophosphamide OF THE TESTS
600mg/m2 D8Vincrstine 1 (PATHOLOGY,
mg/m2 D8 ever RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
557 MO MO005 CT for Gestational Etoposide + Methotrexate + MO005B MO005B1 S 14100 Y N Admission Or Clinical BAR CODE OF THE
Trophoblastic Neoplasia Dactinomycin + Notes,Beta- HCG,CBC,CECT DRUGS,CHARTS OF
CisplatinEtoposide Thorax, abdomen and CHEMOTHERAPY
100mg/m2 IV D1 D2 Pelvis,LFT,RBS,RFT REGIMEN,DISCHARGE
D8Dactinomycin 0.5 mg IV SUMMARY OF INPATIENT
push D1 D2 Methotrexate DEPARTMENT /
300 mg /m2 D1Leucovorin DISCHARGE SUMMARY
15 mg PO every 12 hrs for OF DAY CARE
4 doses Cisplatin 75mg/m2 DEPARTMENT,REPORTS
D8 every 2 weeks OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
558 MO MO005 CT for Gestational MethotrexateMethotrexate MO005C MO005C1 S 1400 Y N Admission Or Clinical BAR CODE OF THE
Trophoblastic Neoplasia 1/mg/kg IM every other day Notes,Beta- HCG,CBC,CECT DRUGS,CHARTS OF
x 4 days D1 3 D5 Thorax, abdomen and CHEMOTHERAPY
D7Alternating every other Pelvis,LFT,RBS,RFT REGIMEN,DISCHARGE
day withLeucovorin 15 mg SUMMARY OF INPATIENT
PO repeat every 14 days DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
559 MO MO005 CT for Gestational DactinomycinInj MO005D MO005D1 S 7700 Y N Beta- HCG,CBC,CECT BAR CODE OF THE
Trophoblastic Neoplasia Dactinomycin 0.5 mg D1- Thorax, abdomen and DRUGS,CHARTS OF
D5 every 14 days Pelvis,LFT,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
560 MO MO006 CT for Cervical Cancer Carboplatin + MO006A MO006A1 S 16400 Y N Biochemistry reports Bar code of the drugs ,BAR
PaclitaxelPaclitaxel (RBS,LFT,RFT, Na, CODE OF THE
175mg/m2 D1Carboplatin K),CBC,CBC ,CECT Thorax, DRUGS,Charts of
AUC 5-6 D1 every 21 days abdomen and Pelvis,Clinical chemotherapy regimen
notes with Details of pelvic ,CHARTS OF
examination (Per speculum CHEMOTHERAPY
and pervaginal examination), REGIMEN,DISCHARGE
planned line of treatment SUMMARY OF INPATIENT
,ECG DEPARTMENT /
,ECHO,histopathology,Histop DISCHARGE SUMMARY
athology report,LFT,M OF DAY CARE
DEPARTMENT,Reports of
hema
561 MO MO006 CT for Cervical Cancer Cisplatin Cisplatin 40 MO006B MO006B1 S 2600 Y N Biochemistry reports Bar code of the drugs ,BAR
mg/m2 every week (LFT,RFT, Na,K),CBC,CBC CODE OF THE
,CECT Thorax, abdomen and DRUGS,Charts of
Pelvis,Clinical notes with chemotherapy regimen
Details of pelvic examination ,CHARTS OF
(Per speculum and CHEMOTHERAPY
pervaginal examination), REGIMEN,DISCHARGE
,ECG DEPARTMENT /
,ECHO,histopathology,Histop DISCHARGE SUMMARY
athology report,LFT,Metast OF DAY CARE
hema
562 MO MO007 CT for Endometrial Cancer Carboplatin + MO007A MO007A1 S 16400 Y N Admission Or Clinical BAR CODE OF THE
PaclitaxelPaclitaxel Notes,CBC,CECT Thorax, DRUGS,CHARTS OF
175mg/m2 D1Carboplatin abdomen and CHEMOTHERAPY
AUC 5 D1 every 21 days Pelvis,histopathology,LFT,RBREGIMEN,DISCHARGE
S,RFT SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
563 MO MO007 CT for Endometrial Cancer Cisplatin + MO007B MO007B1 S 4900 Y N 2D ECHO,Admission Or BAR CODE OF THE
DoxorubicinDoxorubicin 60 Clinical Notes,CBC,CECT DRUGS,CHARTS OF
mg/m2 D1Cisplatin Thorax, abdomen and CHEMOTHERAPY
50mg/m2 every 3 weeks Pelvis,ECG,histopathology,L REGIMEN,DISCHARGE
FT,RBS,RFT SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
564 MO MO007 CT for Endometrial Cancer Lipodox + MO007C MO007C1 S 19000 Y N Beta- HCG,CBC,CECT BAR CODE OF THE
CarboplatinLipopdox 30 Thorax, abdomen and DRUGS,CHARTS OF
mg/m2 D1Carboplatin AUC Pelvis,LFT,RBS,RFT CHEMOTHERAPY
5 D1 every 28 days REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
565 MO MO007 CT for Endometrial Cancer Carboplatin + MO007D MO007D1 S 15300 Y N Beta- HCG,CBC,CECT BAR CODE OF THE
GemcitabineGemcitabine - Thorax, abdomen and DRUGS,CHARTS OF
1000mg/m2 D1 Pelvis,LFT,RBS,RFT CHEMOTHERAPY
D8Carboplatin AUC 2 D1 REGIMEN,DISCHARGE
D8Gemcitabine - SUMMARY OF INPATIENT
1000mg/m2 D1 D8 DEPARTMENT /
Carboplatin AUC 5-6 D1 DISCHARGE SUMMARY
only every 3 weeks OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
566 MO MO007 CT for Endometrial Cancer Anastrozole 1 mg orally MO007E MO007E1 S 4300 Y N Beta- HCG,CBC,CECT BAR CODE OF THE
daily (for 3 months) Thorax, abdomen and DRUGS,CHARTS OF
Pelvis,LFT,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
567 MO MO008 CT for Vulvar Cancer Cisplatin + 5 FU5 FU MO008A MO008A1 S 9100 Y N Admission Or Clinical BAR CODE OF THE
1000mg/m2 D1-D4Cisplatin Notes,CBC,histopathology,LF DRUGS,CHARTS OF
75mg/m2 D1 every 3 weeks T,MRI pelvis,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
568 MO MO008 CT for Vulvar Cancer CisplatinCisplatin 40 mg/m2 MO008B MO008B1 S 2600 Y N Admission Or Clinical BAR CODE OF THE
every week Notes,CBC,histopathology,LF DRUGS,CHARTS OF
T,MRI pelvis,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
569 MO MO008 CT for Vulvar Cancer Carboplatin + MO008C MO008C1 S 16000 Y N CBC,LFT,RBS,RFT CHARTS OF
PaclitaxelPaclitaxel CHEMOTHERAPY
175mg/m2 D1Carboplatin REGIMEN,DISCHARGE
AUC 5 D1 every 21 days SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY OF
DAY CARE
DEPARTMENT,RBS,RFT,TR
ANFUSION SLIPS
570 MO MO009 CT for Ewing Sarcoma Vincristine + Topotecan + MO009A MO009A1 S 25500 Y N 2D ECHO,Admission /clinical Barcode of drugs used,BAR
Cyclophosphamide + notes with history and CODE OF THE
Irinotecan + indication for the procedure, DRUGS,CHARTS OF
TemozolamideVincristine planned line of management CHEMOTHERAPY
1.5mg/m2( day ,Biochemistry,Biopsy,Bone REGIMEN,Charts of
1)Topotecan 1.5mg/m2 marrow studies,CBC,Chest x- chemotherapy regimen &
(day 5)Cyclophosphamide ray/ CECT report ,CT/ USG transfusion
250mg/m2 (days 5)Given guided biospy slips,DISCHARGE
every 3 weeksIrinotecan 10- report,ECG,Histopathology SUMMARY OF INPATIENT
50 mg/sqM days 5 and days report,PET-CT (for DEPARTMENT /
8-12 Temozolamide lymphoma/ DISCHARGE SUMMARY
100mg/m2 5 of each OF DAY CARE
DEPARTMENT,reports of the
tests (pathology, radiology,
571 MO MO009 CT for Ewing Sarcoma Vincristine + Ifosfamide + MO009B MO009B1 S 10900 Y N 2D ECHO,Admission /clinical Barcode of drugs used,BAR
EtoposideVincristine + notes with history and CODE OF THE
Doxorubicin + indication for the procedure, DRUGS,CHARTS OF
CyclophosphamideVincristi planned line of management CHEMOTHERAPY
ne + Cyclophosphamide + ,Biochemistry,Biopsy,Bone REGIMEN,Charts of
Dactinomycin.4 cycles VIE, marrow studies,CBC,Chest x- chemotherapy regimen &
6 cycles VAC, 4 cycles ray/ CECT report ,CT/ USG transfusion
VCDVincristine 1.5mg/m2 guided biospy slips,DISCHARGE
(day 1, 8 and 15)Ifosfamide: report,ECG,Histopathology SUMMARY OF INPATIENT
1800mg/m2 report,PET-CT (for DEPARTMENT /
(days5)Etposide: lymphoma/ DISCHARGE SUMMARY
100mg/sq.m ( OF DAY CARE
572 MO MO009 CT for Ewing Sarcoma Vincristine + Adriamycin + MO009C MO009C1 S 14000 Y N 2D ECHO,Admission /clinical Barcode of drugs used,BAR
CyclophosphamideIfosfami notes with history and CODE OF THE
de + EtoposideIfosfamide: indication for the procedure, DRUGS,CHARTS OF
1800mg/m2 planned line of management CHEMOTHERAPY
(days5)Etposide: ,Biochemistry,Biopsy,Bone REGIMEN,Charts of
100mg/sq.m (days 5)Given marrow studies,CBC,Chest x- chemotherapy regimen &
every 3 weeklyVincristine ray/ CECT report ,CT/ USG transfusion
1.5mg/m2 (day 1 and guided biospy slips,DISCHARGE
8)Adriamyicn: 75mg/m2 report,ECG,Histopathology SUMMARY OF INPATIENT
(day 1)Cyclophosphamide report,PET-CT (for DEPARTMENT /
1200mg/m2 (day 1)Given 3 lymphoma/ DISCHARGE SUMMARY
weekly OF DAY CARE
573 MO MO010 CT for Osteogenic Doxorubicin + MO010A MO010A1 S 13200 Y N 2D ECHO,Audiometry,Blood Bar code of the drugs,BAR
Sarcoma CisplatinCisplatin investigations- CBC,LFT, CODE OF THE
100mg/m2Doxorubicin RFT, RBS,Bone scan or F18 DRUGS,Charts of
75mg/m2 given every 3 PET Scan,CBC,CECT chemotherapy
weeks chest,Clinical notes with regimen,CHARTS OF
documentation of relevant CHEMOTHERAPY
history Bone imaging (local REGIMEN,DISCHARGE
and chest x-ray),Core needle SUMMARY OF INPATIENT
biopsy,DTPA GFR,ECG DEPARTMENT /
,ECHO,GFR DISCHARGE SUMMARY
,histopathology,Histo OF DAY CARE
hemato
574 MO MO010 CT for Osteogenic Methotrexate + Doxorubicin MO010B MO010B1 S 29700 Y N 2D ECHO,Admission Or BAR CODE OF THE
Sarcoma + Cisplatin for Relapsed Clinical DRUGS,CHARTS OF
Osteogenic Notes,AUDIOMETRY,Bioche CHEMOTHERAPY
SarcomaCisplatin mistry,Biopsy,BONE REGIMEN,DISCHARGE
120mg/sq.mDoxorubicin SCAN,CBC,CT SUMMARY OF INPATIENT
75mg/m2Methotrexate 8-12 CHEST,ECG,GFR DEPARTMENT /
gram/m2Each cycle for 5 DISCHARGE SUMMARY
weeks OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
575 MO MO010 CT for Osteogenic OGS - 12 Ifosfamide 1800 MO010C MO010C1 S 32600 Y N 2D ECHO,Audiometry,Blood Bar code of the drugs,BAR
Sarcoma mg/m2 D1-D5Mesna investigations- CBC,LFT, CODE OF THE
600mg/m2 0h 3h 6h 9h D1- RFT, RBS,Bone scan or F18 DRUGS,Charts of
D5Adriamycin 25mg/m2 D1- PET Scan,CBC,CECT chemotherapy
D3Cisplatin 33 mg/m2 D1- chest,Clinical notes with regimen,CHARTS OF
D3 every 21 days documentation of relevant CHEMOTHERAPY
history Bone imaging (local REGIMEN,DISCHARGE
and chest x-ray),Core needle SUMMARY OF INPATIENT
biopsy,DTPA GFR,ECG DEPARTMENT /
,ECHO,GFR DISCHARGE SUMMARY
,histopathology,Histo OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY, HEMATO
576 MO MO010 CT for Osteogenic OGS - 12 Ifosfamide 1800 MO010D MO010D1 S 31500 Y N 2D ECHO,Admission Or BAR CODE OF THE
Sarcoma mg/m2 D1-D5Mesna Clinical Notes,CBC,DTPA DRUGS,CHARTS OF
600mg/m2 0h 3h 6h 9h D1- GFR,histopathology,LFT,Pur CHEMOTHERAPY
D5Cisplatin 33 mg/m2 D1- e tone,RBS,RFT REGIMEN,DISCHARGE
D3 every 21 days SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
577 MO MO011 CT for Soft Tissue Sarcoma Gemcitabine + MO011A MO011A1 S 26400 Y N Blood investigations- Bar code of the drugs,BAR
DocetaxelGemcitabine 900 CBC,LFT, RFT, CODE OF THE
mg/m2 D1 D8Docetaxel RBS,CBC,CECT/ MRI thorax, DRUGS,CHARTS OF
100 mg/m2 D8 every 21 abdomen, pelvis,CECT CHEMOTHERAPY
days Thorax, abdomen and REGIMEN,Charts of
Pelvis,Chest X-ray,Clinical chemotherapy regimen,
notes with documentation of transfusion
relevant history, signs, slips,DISCHARGE
symptoms, indication SUMMARY OF INPATIENT
including stage,ECHO,ECHO DEPARTMENT /
report,histopathology,LFT DISCHARGE SUMMARY
OF DAY CARE
radiology, m
578 MO MO011 CT for Soft Tissue Sarcoma Ifosfamide + MO011B MO011B1 S 15100 Y N Blood investigations- Bar code of the drugs,BAR
AdriamycinDoxorubicin CBC,LFT, RFT, CODE OF THE
30mg/m2 D1 D2Ifosfamide RBS,CBC,CECT/ MRI thorax, DRUGS,CHARTS OF
2000 to 3000mg/m2Mesna abdomen, pelvis,CECT CHEMOTHERAPY
400 to 600 mg/m2 0h 4h 8h Thorax, abdomen and REGIMEN,Charts of
D1 - D3Every 21 days Pelvis,Chest X-ray,Clinical chemotherapy regimen,
including stage,ECHO,ECHO DEPARTMENT /
report,histopathology,LFT DISCHARGE SUMMARY
OF DAY CARE
radiology, m
579 MO MO011 CT for Soft Tissue Sarcoma Doxorubicin 60-75/m2, MO011C MO011C1 S 4400 Y N CBC,CECT Thorax, abdomen BAR CODE OF THE
every 21 days and DRUGS,CHARTS OF
Pelvis,ECHO,histopathology, CHEMOTHERAPY
LFT,MRI of the involved part REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
580 MO MO012 CT for Metastatic Dacarbazine + MO012A MO012A1 S 7900 Y N Admission/ clinical notes with Bar code of the drugs,BAR
Melanoma CisplatinDacarbazine complete history, physical CODE OF THE
250mg/m2 D1-D5Cisplatin examinations, indications and DRUGS,Charts of
75 mg/m2 Every 21 days plan of chemotherapy regimen
treatment,Biochemistry (RBS, ,CHARTS OF
LFT, RFT, LDH) ,CBC,CBC CHEMOTHERAPY
,CECT/ PET-CT Chest, REGIMEN,DISCHARGE
Abdomen and Pelvis/Chest X- SUMMARY OF INPATIENT
ray ,CECT Thorax, abdomen DEPARTMENT /
and DISCHARGE SUMMARY
Pelvis,histopathology,LFT,Pe OF DAY CARE
hemat
581 MO MO012 CT for Metastatic TemozolamideTemozolami MO012B MO012B1 S 5500 Y N Admission/ clinical notes with Bar code of the drugs,BAR
Melanoma de 200mg/m2 D1-D5 every complete history, physical CODE OF THE
28 days examinations, indications and DRUGS,Charts of
plan of chemotherapy regimen
treatment,Biochemistry (RBS, ,CHARTS OF
LFT, RFT, LDH) ,CBC,CBC CHEMOTHERAPY
,CECT/ PET-CT Chest, REGIMEN,DISCHARGE
Abdomen and Pelvis/Chest X- SUMMARY OF INPATIENT
ray ,CECT Thorax, abdomen DEPARTMENT /
and Pelvis,LFT,Peripheral DISCHARGE SUMMARY
blood OF DAY CARE
hemat
582 MO MO012 CT for Metastatic Imatinib Tab Imatinib MO012C MO012C1 S 5500 Y N CBC,CECT Thorax, abdomen BAR CODE OF THE
Melanoma 400/800 mg daily and DRUGS,CHARTS OF
Pelvis,histopathology,LFT,RB CHEMOTHERAPY
S,RFT REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
583 MO MO013 CT for Anal Cancer 5 Fluorouracil (FU)+ MO013A MO013A1 S 12100 Y N Biopsy/ Histopathology Bar code of the drugs,BAR
Mitomycin C5 report,Blood investigations- CODE OF THE
Fluorouracil(FU) CBC,LFT, RFT, RBS, HIV DRUGS,CHARTS OF
1000mg/m2 D1-D4 D29- testing, CD4 CHEMOTHERAPY
D32Mitomycin 10mg/m2 D1 counts,Carcinoembryonic REGIMEN,Charts of
antigen chemotherapy regimen,
(CEA),CBC,CEA,CECT transfusion
Thorax, abdomen,Clinical slips,DISCHARGE
notes with documentation of SUMMARY OF INPATIENT
relevant history (anal growth DEPARTMENT /
or mass/ bleeding per DISCHARGE SUMMARY
rectum) and OF DAY CARE
radiology, m
584 MO MO013 CT for Anal Cancer Capecitabine + Mitomycin C MO013B MO013B1 S 18600 Y N Biopsy/ Histopathology Bar code of the drugs,BAR
Capecitabine 825mg/m2 report,Blood investigations- CODE OF THE
PO twice daily till CBC,LFT, RFT, RBS, HIV DRUGS,CHARTS OF
completion of RTMitomycin testing, CD4 CHEMOTHERAPY
10mg/2 D1 counts,Carcinoembryonic REGIMEN,Charts of
Thorax, abdomen,Clinical slips,DISCHARGE
relevant history (anal growth DEPARTMENT /
or mass/ bleeding per DISCHARGE SUMMARY
rectum) and OF DAY CARE
radiology, m
585 MO MO013 CT for Anal Cancer Cisplatin + 5 FU5 FU MO013C MO013C1 S 9000 Y N Biopsy/ Histopathology Bar code of the drugs,BAR
1000mg/m2 D1-D4Cisplatin report,Blood investigations- CODE OF THE
75mg/m2 D1 every 4 weeks CBC,LFT, RFT, RBS, HIV DRUGS,CHARTS OF
testing, CD4 CHEMOTHERAPY
counts,Carcinoembryonic REGIMEN,Charts of
Thorax, abdomen, slips,DISCHARGE
Pelvis,Clinical notes with SUMMARY OF INPATIENT
documentation of relevant DEPARTMENT /
history (anal growth or mass/ DISCHARGE SUMMARY
bleeding per rect OF DAY CARE
radiology, m
586 MO MO013 CT for Anal Cancer Carboplatin + MO013D MO013D1 S 16400 Y N Biopsy/ Histopathology Bar code of the drugs,BAR
PaclitaxelPaclitaxel report,Blood investigations- CODE OF THE
175mg/m2 D1Carboplatin CBC,LFT, RFT, RBS, HIV DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days testing, CD4 CHEMOTHERAPY
radiology, m
587 MO MO013 CT for Anal Cancer Cisplatin + MO013E MO013E1 S 14700 Y N Biopsy/ Histopathology Bar code of the drugs,BAR
PaclitaxelPaclitaxel 175 report,Blood investigations- CODE OF THE
mg/m2 D1Cisplatin CBC,LFT, RFT, RBS, HIV DRUGS,CHARTS OF
75mg/m2 D1 every 21 days testing, CD4 CHEMOTHERAPY
radiology, m
588 MO MO014 CT for Colorectal Cancer 5 FU + Leucovorin5 FU MO014A MO014A1 S 6100 Y N Blood investigations- Bar code of the drugs,BAR
1200mg/m2 D1 CBC,LFT, RFT, CODE OF THE
D2Leucovorin 400mg/m2 RBS,Carcinoembryonic DRUGS,CHARTS OF
D1 every 14 days antigen CHEMOTHERAPY
(CEA),CBC,CEA,CECT REGIMEN,Charts of
Thorax, abdomen, chemotherapy regimen,
Pelvis,CECT Thorax, transfusion
abdomen & Pelvis; Chest X- slips,DISCHARGE
ray,Clinical notes with SUMMARY OF INPATIENT
history, signs, symptoms, DISCHARGE SUMMARY
indication including OF DAY CARE
stage,Colono DEPARTMENT,Reports of
radiology, m
589 MO MO014 CT for Colorectal Cancer Capecitabine + MO014B MO014B1 S 13800 Y N Blood investigations- Bar code of the drugs,BAR
IrinotecanCapecitabine CBC,LFT, RFT, CODE OF THE
1000mg/m2 D1- RBS,Carcinoembryonic DRUGS,CHARTS OF
D14Irinotecan 200 mg/m2 antigen CHEMOTHERAPY
D1 every 21 days (CEA),CBC,CEA,CECT REGIMEN,Charts of
radiology, m
590 MO MO014 CT for Colorectal Cancer 5 FU + Leucovorin + MO014C MO014C1 S 15100 Y N Blood investigations- Bar code of the drugs,BAR
Oxaliplatin5 FU 1200mg/m2 CBC,LFT, RFT, CODE OF THE
D1 D2Leucovorin RBS,Carcinoembryonic DRUGS,CHARTS OF
400mg/m2 D1Oxaliplatin 85 antigen CHEMOTHERAPY
mg/m2 D1 every 14 days (CEA),CBC,CEA,CECT REGIMEN,Charts of
radiology, m
591 MO MO014 CT for Colorectal Cancer 5FU + Leucovorin + MO014D MO014D1 S 10600 Y N Blood investigations- Bar code of the drugs,BAR
Irinotecan5 FU 1200mg/m2 CBC,LFT, RFT, CODE OF THE
D1 D2Leucovorin RBS,Carcinoembryonic DRUGS,CHARTS OF
400mg/m2 D1Irinotecan antigen CHEMOTHERAPY
180mg/m2 85 mg/m2 D1 (CEA),CBC,CEA,CECT REGIMEN,Charts of
every 14 days Thorax, abdomen, chemotherapy regimen,
radiology, m
592 MO MO014 CT for Colorectal Cancer Capecitabine + MO014E MO014E1 S 13800 Y N Blood investigations- Bar code of the drugs,BAR
OxaliplatinCapecitabine CBC,LFT, RFT, CODE OF THE
1000mg/m2 D1- RBS,Carcinoembryonic DRUGS,CHARTS OF
D14Oxaliplatin 130 mg/m2 antigen CHEMOTHERAPY
D1 every 21 days (CEA),CBC,CEA,CECT REGIMEN,Charts of
radiology, m
593 MO MO014 CT for Colorectal Cancer Capecitabine along with MO014F MO014F1 S 8000 Y N Blood investigations- Bar code of the drugs,BAR
RTCapecitabine 825 mg/m2 CBC,LFT, RFT, CODE OF THE
twice daily RBS,Carcinoembryonic DRUGS,CHARTS OF
antigen CHEMOTHERAPY
radiology, m
594 MO MO014 CT for Colorectal Cancer CapecitabineCapecitabine MO014G MO014G1 S 8100 Y N Blood investigations- Bar code of the drugs,BAR
1000mg/m2 D1-D14 every CBC,LFT, RFT, CODE OF THE
21 days RBS,Carcinoembryonic DRUGS,CHARTS OF
antigen CHEMOTHERAPY
radiology, m
595 MO MO014 CT for Colorectal Cancer 5FU + Leucovorin + MO014H MO014H1 S 20700 Y N Blood investigations- Bar code of the drugs,BAR
Oxaliplatin + Irinotecan5 FU CBC,LFT, RFT, CODE OF THE
1200mg/m2 D1 RBS,Carcinoembryonic DRUGS,CHARTS OF
D2Leucovorin 400mg/m2 antigen CHEMOTHERAPY
D1Oxaliplatin 85 mg/m2 (CEA),CBC,CEA,CECT REGIMEN,Charts of
D1Irinotecan 180mg/m2 Thorax, abdomen, chemotherapy regimen,
every 14 days Pelvis,CECT Thorax, transfusion
radiology, m
596 MO MO015 CT for Esophageal Cancer Carboplatin + MO015A MO015A1 S 16400 Y N Biopsy/ histopathology Barcode of drugs used,BAR
PaclitaxelPaclitaxel report,Blood investigation CODE OF THE
175mg/m2 D1Carboplatin reports such as CBC, LFT, DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days RFT, RBS,CBC,CECT CHEMOTHERAPY
Thorax, abdomen, REGIMEN,Charts of
Pelvis,CECT Thorax, chemotherapy regimen &
abdomen, pelvis transfusion
reports,Clinical notes with slips,DISCHARGE
indications including stage, SUMMARY OF INPATIENT
signs, symptoms, relevant DEPARTMENT /
history/ risk factors, pl DISCHARGE SUMMARY
OF DAY CARE
597 MO MO015 CT for Esophageal Cancer Cisplatin + 5 FU5 FU MO015B MO015B1 S 10700 Y N Biopsy/ histopathology Barcode of drugs used,BAR
1000mg/m2 D1-D4Cisplatin report,Blood investigation CODE OF THE
75mg/m2 D1 every 4 weeks reports such as CBC, LFT, DRUGS,CHARTS OF
RFT, RBS,CBC,CECT CHEMOTHERAPY
OF DAY CARE
598 MO MO015 CT for Esophageal Cancer Cisplatin + 5 FUCisplatin MO015C MO015C1 S 15600 Y N Biopsy/ histopathology Barcode of drugs used,BAR
75mg/m2 D1 D295FU report,Blood investigation CODE OF THE
1000mg/m2 D1-D4 D29 reports such as CBC, LFT, DRUGS,CHARTS OF
D32 every 35 RFT, RBS,CBC,CECT CHEMOTHERAPY
OF DAY CARE
599 MO MO015 CT for Esophageal Cancer Paclitaxel + MO015D MO015D1 S 29900 Y N Biopsy/ histopathology Barcode of drugs used,BAR
CarboplatinPaclitaxel report,Blood investigation CODE OF THE
AUC 2 D1 every week RFT, RBS,CBC,CECT CHEMOTHERAPY
OF DAY CARE
600 MO MO015 CT for Esophageal Cancer Paclitaxel + MO015E MO015E1 S 29900 Y N Biopsy/ histopathology Barcode of drugs used,BAR
CarboplatinPaclitaxel report,Blood investigation CODE OF THE
AUC 2 D1 every week RFT, RBS,CBC,CECT CHEMOTHERAPY
OF DAY CARE
601 MO MO016 CT for Esophageal / Cisplatin + MO016A MO016A1 S 15300 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer DocetaxelDocetaxel report,Blood investigations- CODE OF THE
40mg/m2 D1Cisplatin 40 CBC,LFT, RFT, DRUGS,CHARTS OF
mg/m2 D1Leucovorin RBS,CBC,CECT thorax, CHEMOTHERAPY
400mg/m2 D15FU abdomen, pelvis,CECT REGIMEN,Charts of
1000mg/m2 D1 D2 every 14 Thorax, abdomen, chemotherapy regimen,
days Pelvis,Clinical notes with transfusion
documentation of relevant slips,DISCHARGE
history, risk factors,signs, SUMMARY OF INPATIENT
symptoms, indication DEPARTMENT /
including staging of treatmen DISCHARGE SUMMARY
OF DAY CARE
radiology, m
602 MO MO016 CT for Esophageal / IrinotecanIrinotecan 60- 90 MO016B MO016B1 S 12100 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer mg/m2 D1 D8 every 21 report,Blood investigations- CODE OF THE
days CBC,LFT, RFT, DRUGS,CHARTS OF
RBS,CBC,CECT thorax, CHEMOTHERAPY
abdomen, pelvis,CECT REGIMEN,Charts of
Pelvis,Clinical notes with transfusion
OF DAY CARE
radiology, m
603 MO MO016 CT for Esophageal / 5 FU5 FU 250 mg/m2 D1- MO016C MO016C1 S 10400 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer D5 over 24 hrs every week report,Blood investigations- CODE OF THE
CBC,LFT, RFT, DRUGS,CHARTS OF
OF DAY CARE
radiology, m
604 MO MO016 CT for Esophageal / CapecitabineCapecitabine MO016D MO016D1 S 8000 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer 825 mg/m2 twice daily report,Blood investigations- CODE OF THE
OF DAY CARE
radiology, m
605 MO MO016 CT for Esophageal / Capecitabine + MO016E MO016E1 S 13800 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer OxaliplatinCapecitabine report,Blood investigations- CODE OF THE
1000mg/m2 D1- CBC,LFT, RFT, DRUGS,CHARTS OF
D14Oxaliplatin 130 mg/m2 RBS,CBC,CECT thorax, CHEMOTHERAPY
D1 every 21 days abdomen, pelvis,CECT REGIMEN,Charts of
OF DAY CARE
radiology, m
606 MO MO016 CT for Esophageal / Docetaxel + Cisplatin + 5 MO016F MO016F1 S 16000 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer FUDocetaxel 40mg/m2 report,Blood investigations- CODE OF THE
D1Cisplatin 40 mg/m2 CBC,LFT, RFT, DRUGS,CHARTS OF
D1Leucovorin 400mg/m2 RBS,CBC,CECT thorax, CHEMOTHERAPY
D15FU 1000mg/m2 D1 D2 abdomen, pelvis,CECT REGIMEN,Charts of
OF DAY CARE
radiology, m
607 MO MO016 CT for Esophageal / Docetaxel + Cisplatin + MO016G MO016G1 S 16000 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer CapecitabineDocetaxel report,Blood investigations- CODE OF THE
40mg/m2 D1Cisplatin 40 CBC,LFT, RFT, DRUGS,CHARTS OF
mg/m2 D1Capecitabine RBS,CBC,CECT thorax, CHEMOTHERAPY
825mg/m2 twice daily every abdomen, pelvis,CECT REGIMEN,Charts of
14 days Thorax, abdomen, chemotherapy regimen,
OF DAY CARE
radiology, m
608 MO MO016 CT for Esophageal / Docetaxel + Oxaliplatin + 5 MO016H MO016H1 S 20400 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer FUDocetaxel 50mg/m2 report,Blood investigations- CODE OF THE
D1Oxaliplatin 85 mg/m2 CBC,LFT, RFT, DRUGS,CHARTS OF
D1Leucovorin 400mg/m2 RBS,CBC,CECT thorax, CHEMOTHERAPY
D15FU 1200mg/m2 D1 D2 abdomen, pelvis,CECT REGIMEN,Charts of
OF DAY CARE
radiology, m
609 MO MO016 CT for Esophageal / Docetaxel + Oxaliplatin + MO016I MO016I1 S 20400 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer CapecitabineDocetaxel report,Blood investigations- CODE OF THE
50mg/m2 D1Oxaliplatin 85 CBC,LFT, RFT, DRUGS,CHARTS OF
mg/m2 D1Capecitabine 825 RBS,CBC,CECT thorax, CHEMOTHERAPY
mg/m2 Twice daily every 14 abdomen, pelvis,CECT REGIMEN,Charts of
days Thorax, abdomen, chemotherapy regimen,
OF DAY CARE
radiology, m
610 MO MO016 CT for Esophageal / 5FU + Leucovorin + MO016J MO016J1 S 10600 Y N Biopsy, Histopathology Bar code of the drugs,BAR
Stomach Cancer Irinotecan5 FU 1200mg/m2 report,Blood investigations- CODE OF THE
D1 D2Leucovorin CBC,LFT, RFT, DRUGS,CHARTS OF
400mg/m2 D1Irinotecan RBS,CBC,CECT thorax, CHEMOTHERAPY
180mg/m2 85 mg/m2 D1 abdomen, pelvis,CECT REGIMEN,Charts of
including staging of treatme DISCHARGE SUMMARY
OF DAY CARE
radiology, m
611 MO MO016 CT for Esophageal / 5FU + Leucovorin + MO016K MO016K1 S 15100 Y N Biopsy, Histopathology Bar code of the drugs,BAR
Stomach Cancer Oxaliplatin5 FU 1200mg/m2 report,Blood investigations- CODE OF THE
D1 D2Leucovorin CBC,LFT, RFT, DRUGS,CHARTS OF
400mg/m2 D1Oxaliplatin 85 RBS,CBC,CECT thorax, CHEMOTHERAPY
mg/m2 D1 every 14 days abdomen, pelvis,CECT REGIMEN,Charts of
including staging of treatme DISCHARGE SUMMARY
OF DAY CARE
radiology, m
612 MO MO016 CT for Esophageal / PaclitaxelPaclitaxel MO016L MO016L1 S 6600 Y N Biopsy/Histopathology Bar code of the drugs,BAR
Stomach Cancer 80mg/m2 every week report,Blood investigations- CODE OF THE
OF DAY CARE
radiology, m
613 MO MO017 CT for Hepatocellular Doxorubicin MO017A MO017A1 S 24800 Y N AFP,Blood investigations- Bar code of the drugs,BAR
Carcinoma (TACE)Doxorubicin 30-75 CBC,LFT, RFT, CODE OF THE
mg/m2 one course RBS,CBC,Clinical notes with DRUGS,CHARTS OF
documentation of relevant CHEMOTHERAPY
history, signs, symptoms, REGIMEN,Charts of
indication including chemotherapy regimen,
stage,Documentation of Child transfusion
scoring and BCLC slips,DISCHARGE
scoring,Gadolinium SUMMARY OF INPATIENT
enhanced MRI of the DEPARTMENT /
abdomen (in cirrhotics and DISCHARGE SUMMARY
sus OF DAY CARE
radiology, m
614 MO MO017 CT for Hepatocellular SorafenibSorafenib 400mg MO017B MO017B1 S 9900 Y N 2D ECHO,AFP,Blood Bar code of the drugs,BAR
Carcinoma PO twice daily investigations-CBC,LFT, CODE OF THE
RFT, RBS,CBC,Clinical notes DRUGS,CHARTS OF
with documentation of CHEMOTHERAPY
relevant history, signs, REGIMEN,DISCHARGE
including DEPARTMENT /
stage,Documentation of Child DISCHARGE SUMMARY
scoring and BCLC OF DAY CARE
scoring,Gadolinium DEPARTMENT,Reports of
enhanced MRI of the the tests (pathology,
abdomen (in cirrhotics radiology, microbiology,
hematology, biochemistry,
etc.),REPOR
615 MO MO017 CT for Hepatocellular Lenvatinib 12 mg daily MO017C MO017C1 S 18700 Y N AFP,CBC,CECT Thorax, BAR CODE OF THE
Carcinoma abdomen and DRUGS,CHARTS OF
Pelvis,histopathology,LFT,M CHEMOTHERAPY
RI,RBS,RFT REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
616 MO MO018 CT for Panceratic Cancer Gemcitabine + MO018A MO018A1 S 31300 Y N Blood investigations- Bar code of the drugs,BAR
NanopaclitaxelGemcitabine CBC,LFT, RFT, RBS, CODE OF THE
1000mg/m2 D1 D8 Coagulation DRUGS,CHARTS OF
D16Albumin bound profile,CA19.9,CBC,CECT CHEMOTHERAPY
Paclitaxel 125mg/m2 D1 D8 Thorax, abdomen, REGIMEN,Charts of
D15 every 28 days Pelvis,Chest X-ray,Clinical chemotherapy regimen,
including staging of DEPARTMENT /
treatment,CT/ USG guided DISCHARGE SUMMARY
FNAC / Biopsy OF DAY CARE
radiology, m
617 MO MO018 CT for Panceratic Cancer Gemcitabine 1000mg /m2 MO018B MO018B1 S 9900 Y N Blood investigations- Bar code of the drugs,BAR
D1 D8 every 21 days CBC,LFT, RFT, RBS, CODE OF THE
Coagulation DRUGS,CHARTS OF
profile,CA19.9,CBC,CECT CHEMOTHERAPY
radiology, m
618 MO MO018 CT for Panceratic Cancer Gemcitabine 300mg/m2 MO018C MO018C1 S 4400 Y N Blood investigations- Bar code of the drugs,BAR
weekly CBC,LFT, RFT, RBS, CODE OF THE
radiology, m
619 MO MO018 CT for Panceratic Cancer 5FU + Leucovorin + MO018D MO018D1 S 20800 Y N Blood investigations- Bar code of the drugs,BAR
Oxaliplatin + Irinotecan5 FU CBC,LFT, RFT, RBS, CODE OF THE
1200mg/m2 D1 Coagulation DRUGS,CHARTS OF
D2Leucovorin 400mg/m2 profile,CA19.9,CBC,CECT CHEMOTHERAPY
D1Oxaliplatin 85 mg/m2 Thorax, abdomen, REGIMEN,Charts of
D1Irinotecan 180mg/m2 Pelvis,Chest X-ray,Clinical chemotherapy regimen,
every 14 days notes with documentation of transfusion
radiology, m
620 MO MO018 CT for Panceratic Cancer CapecitabineCapecitabine MO018E MO018E1 S 8000 Y N Blood investigations- Bar code of the drugs,BAR
825 mg/m2 twice daily CBC,LFT, RFT, RBS, CODE OF THE
radiology, m
621 MO MO018 CT for Panceratic Cancer Capecitabine + MO018F MO018F1 S 37600 Y N Blood investigations- Bar code of the drugs,BAR
GemcitabineGemcitabine CBC,LFT, RFT, RBS, CODE OF THE
1000mg/m2 D1 D8 Coagulation DRUGS,CHARTS OF
D15Capecitabine profile,CA19.9,CBC,CECT CHEMOTHERAPY
830mg/m2 twice daily D1- Thorax, abdomen, REGIMEN,Charts of
D21 every 28 days Pelvis,Chest X-ray,Clinical chemotherapy regimen,
radiology, m
622 MO MO019 CT for Gall Bladder Cancer CapecitabineCapecitabine MO019A MO019A1 S 8100 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma 1000 - 1250 mg/m2 twice CBC,LFT, RFT, CODE OF THE
daily D1 -D14 every 21 RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
days report,Carcinoembryonic CHEMOTHERAPY
antigen (CEA) report REGIMEN,Charts of
,CBC,CECT Abdomen chemotherapy regimen,
&Pelvis ,CECT Thorax, transfusion
abdomen, Pelvis,Clinical slips,DISCHARGE
relevant history, signs, DEPARTMENT /
symptoms, indication DISCHARGE SUMMARY
including staging OF DAY CARE
radiology, m
623 MO MO019 CT for Gall Bladder Cancer Cisplatin + MO019B MO019B1 S 13400 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma GemcitabineGemcitabine CBC,LFT, RFT, CODE OF THE
1000 mg/m2 D1 RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
D8Cisplatin 25 mg/m2 D1 report,Carcinoembryonic CHEMOTHERAPY
D8 every 21 days antigen (CEA) report REGIMEN,Charts of
radiology, m
624 MO MO019 CT for Gall Bladder Cancer 5FU + Leucovorin + MO019C MO019C1 S 10600 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma Irinotecan5 FU 1200mg/m2 CBC,LFT, RFT, CODE OF THE
D1 D2Leucovorin RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
400mg/m2 D1Irinotecan report,Carcinoembryonic CHEMOTHERAPY
180mg/m2 85 mg/m2 D1 antigen (CEA) report REGIMEN,Charts of
every 14 days ,CBC,CECT Abdomen chemotherapy regimen,
radiology, m
625 MO MO019 CT for Gall Bladder Cancer GemcitabineGemcitabine MO019D MO019D1 S 4400 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma 300 mg/m2 D 1every week CBC,LFT, RFT, CODE OF THE
(till RT ends) - per week RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
report,Carcinoembryonic CHEMOTHERAPY
radiology, m
626 MO MO019 CT for Gall Bladder Cancer GemcitabineGemcitabine MO019E MO019E1 S 9900 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma 1000mg /m2 D1 D8 every CBC,LFT, RFT, CODE OF THE
21 days RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
report,Carcinoembryonic CHEMOTHERAPY
radiology, m
627 MO MO019 CT for Gall Bladder Cancer Oxaliplatin + MO019F MO019F1 S 19200 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma GemcitabineGemcitabine CBC,LFT, RFT, CODE OF THE
1000 mg/m2 D1Oxaliplatin RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
100 mg/m2 D1 every 14 report,Carcinoembryonic CHEMOTHERAPY
days antigen (CEA) report REGIMEN,Charts of
radiology, m
628 MO MO019 CT for Gall Bladder Cancer Capecitabine + MO019G MO019G1 S 13800 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma IrinotecanCapecitabine CBC,LFT, RFT, CODE OF THE
1000mg/m2 D1- RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
D14Irinotecan 200 mg/m2 report,Carcinoembryonic CHEMOTHERAPY
D1 every 21 days antigen (CEA) report REGIMEN,Charts of
radiology, m
629 MO MO019 CT for Gall Bladder Cancer 5FU + Leucovorin + MO019H MO019H1 S 15100 Y N Blood investigations- Bar code of the drugs,BAR
/ Cholangiocarcinoma Oxaliplatin5 FU 1200mg/m2 CBC,LFT, RFT, CODE OF THE
D1 D2Leucovorin RBS,CA19.9,CA 19.9 DRUGS,CHARTS OF
400mg/m2 D1Oxaliplatin 85 report,Carcinoembryonic CHEMOTHERAPY
mg/m2 D1 every 14 days antigen (CEA) report REGIMEN,Charts of
radiology, m
630 MO MO020 CT for Gastointestinal ImatinibImatinib 400 mg MO020A MO020A1 S 16500 Y N Blood investigations- Bar code of the drugs,BAR
stromal tumor once daily CBC,LFT, RFT, CODE OF THE
RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
abdomen, Pelvis,CECT CHEMOTHERAPY
Thorax, Abdomen &Pelvis REGIMEN,Charts of
,Chest X-ray,Ckit-mutation chemotherapy regimen &
(not mandatory),C-kit transfusion slips,Discharge
(positivity) on summary of inpatient/daycare
Immunohistochemistry (IHC) department,DISCHARGE
,Clinical notes with SUMMARY OF INPATIENT
history, signs, DISCHARGE SUMMARY OF
DAY CARE DEPAR
631 MO MO020 CT for Gastointestinal SunitinibSunitinb 37.5 mg MO020B MO020B1 S 11000 Y N Blood investigations- Bar code of the drugs,BAR
stromal tumor once daily CBC,LFT, RFT, CODE OF THE
abdomen, Pelvis,CECT CHEMOTHERAPY
Thorax, Abdomen &Pelvis REGIMEN,Charts of
,Chest X-ray,Ckit-mutation chemotherapy regimen &
(not mandatory),C-kit transfusion slips,Discharge
(positivity) on summary of inpatient/daycare
Immunohistochemistry (IHC) department,DISCHARGE
history, signs, DISCHARGE SUMMARY OF
DAY CARE DEPAR
632 MO MO021 CT for CA Brain TemozolamideTemozolomi MO021A MO021A1 S 5500 Y N Admission Or Clinical BAR CODE OF THE
de 150 - 200 mg/m2 D1-D5 Notes,CBC,histopathology,LF DRUGS,CHARTS OF
every 28 days T,MRI brain,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
633 MO MO021 CT for CA Brain TemozolamideTemozolomi MO021B MO021B1 S 33000 Y N Admission Or Clinical BAR CODE OF THE
de 75mg/m2 once daily Notes,CBC,histopathology,LF DRUGS,CHARTS OF
T,MRI brain,RBS,RFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
634 MO MO022 CT for Mesothelioma Gemcitabine + MO022A MO022A1 S 13400 Y N Admission/ clinical notes with Barcode of drugs used,BAR
CisplatinGemcitabine 1000 complete history, physical CODE OF THE
mg/m2 D1 D8Cisplatin 75 examinations, indications and DRUGS,CHARTS OF
mg/m2 D1 every 21 days plan of treatment,Blood CHEMOTHERAPY
Investigations: CBC, RBS, REGIMEN,Charts of
LFT, RFT, LDH,CBC,CECT/ chemotherapy regimen &
PET-CT Chest, Abdomen transfusion
and Pelvis,CECT Thorax, slips,DISCHARGE
abdomen, Pelvis,Chest X- SUMMARY OF INPATIENT
ray,FNAC of pleural/ pe DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
635 MO MO022 CT for Mesothelioma Pemetrexed + MO022B MO022B1 S 10400 Y N Admission/ clinical notes with Barcode of drugs used,BAR
CisplatinPemetrexed complete history, physical CODE OF THE
500mg/m2 D1Cisplatin 75 examinations, indications and DRUGS,CHARTS OF
mg/m2 D1 every 21 days plan of treatment,Blood CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
636 MO MO022 CT for Mesothelioma Pemetrexed + MO022C MO022C1 S 11200 Y N Admission/ clinical notes with Barcode of drugs used,BAR
CarboplatinPemetrexed complete history, physical CODE OF THE
500mg/m2 D1Carboplatin examinations, indications and DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days plan of treatment,Blood CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
637 MO MO023 CT for Thymic Carcinoma Cisplatin + MO023A MO023A1 S 7800 Y N Admission/ clinical notes with Barcode of drugs used,BAR
EtoposideEtoposide complete history, Physical CODE OF THE
100mg/m2 D1 - D3Cisplatin examinations, Indications and DRUGS,CHARTS OF
75-100 mg/m2 D1 every 21 plan of treatment.,Blood CHEMOTHERAPY
days Investigations: CBC, RBS, REGIMEN,Charts of
LFT, RFT, LDH,CBC,CECT chemotherapy regimen &
Thorax, abdomen, transfusion
Pelvis,CECT Thorax, slips,DISCHARGE
abdomen, pelvis reports,CT SUMMARY OF INPATIENT
guided biopsy to be done DEPARTMENT /
only DISCHARGE SUMMARY
OF DAY CARE
638 MO MO023 CT for Thymic Carcinoma Cisplatin + Adriamycin + MO023B MO023B1 S 6500 Y N Admission/ clinical notes with Barcode of drugs used,BAR
CyclophosphamideCisplatin complete history, Physical CODE OF THE
50 mg/m2 D1Doxorubicin examinations, Indications and DRUGS,CHARTS OF
50 mg/m2 plan of treatment.,Blood CHEMOTHERAPY
D1Cyclophosphamide 500 Investigations: CBC, RBS, REGIMEN,Charts of
mg/m2 D1 every 21 days LFT, RFT, LDH,CBC,CECT chemotherapy regimen &
Thorax, abdomen, transfusion
Pelvis,CECT Thorax, slips,DISCHARGE
abdomen, pelvis reports,CT SUMMARY OF INPATIENT
guided biopsy to be done DEPARTMENT /
only DISCHARGE SUMMARY
OF DAY CARE
639 MO MO024 CT for CA Head & Neck Cisplatin + MO024A MO024A1 S 13700 Y N Blood investigations- CBC, Barcode of drugs used,BAR
DocetaxelDocetaxel 75 RFT, LFT, RBS,CBC,CECT CODE OF THE
mg/m2 D1Cisplatin 75 /MR face & Neck,CECT/MRI DRUGS,Blood investigations-
mg/m2 D1 every 21 days Face and neck,Chest X-ray CBC, RFT, LFT, S.
report,Clinical notes with Creatinine,CHARTS OF
complete history, risk factors, CHEMOTHERAPY
staging with subsite REGIMEN,Charts of
involvement, physical chemotherapy regimen &
examinations, indications transfusion
including signs, symptoms, slips,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
640 MO MO024 CT for CA Head & Neck CisplatinCisplatin MO024B MO024B1 S 10800 Y N Blood investigations- CBC, Barcode of drugs used,BAR
100mg/m2 every 21 days RFT, LFT, RBS,CBC,CECT CODE OF THE
/MR face & Neck,CECT/MRI DRUGS,Blood investigations-
Face and neck,Chest X-ray CBC, RFT, LFT, S.
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
641 MO MO024 CT for CA Head & Neck Carboplatin + MO024C MO024C1 S 15300 Y N Blood investigations- CBC, Barcode of drugs used,BAR
GemcitabineGemcitabine RFT, LFT, RBS,CBC,CECT CODE OF THE
1000 mg/m2 D1 /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
D8Carboplatin AUC 5-6 D1 report,Clinical notes with CBC, RFT, LFT, S.
every 21 days complete history, risk factors, Creatinine,CHARTS OF
staging with subsite CHEMOTHERAPY
involvement, physical REGIMEN,Charts of
examinations, indications chemotherapy regimen &
including signs, symptoms, transfusion
stage and planned line slips,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
642 MO MO024 CT for CA Head & Neck Docetaxel + Cisplatin + 5 MO024D MO024D1 S 16000 Y N Blood investigations- CBC, Barcode of drugs used,BAR
FUDocetaxel 75 mg/m2 RFT, LFT, RBS,CBC,CECT CODE OF THE
D1Cisplatin 75 mg/m2 D15 /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
FU 750 mg/m2 D1- D5 report,Clinical notes with CBC, RFT, LFT, S.
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
643 MO MO024 CT for CA Head & Neck DocetaxelDocetaxel MO024E MO024E1 S 3600 Y N Blood investigations- CBC, Barcode of drugs used,BAR
20mg/m2 every week RFT, LFT, RBS,CBC,CECT CODE OF THE
/MR face & Neck,Chest X-ray DRUGS,Blood investigations-
report,Clinical notes with CBC, RFT, LFT, S.
complete history, risk factors, Creatinine,CHARTS OF
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
644 MO MO024 CT for CA Head & Neck DocetaxelDocetaxel 75 MO024F MO024F1 S 9400 Y N Blood investigations- CBC, Barcode of drugs used,BAR
mg/m2 D1 every 21 days RFT, LFT, RBS,CBC,CECT CODE OF THE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
645 MO MO024 CT for CA Head & Neck Etoposide + MO024G MO024G1 S 8500 Y N Blood investigations- CBC, Barcode of drugs used,BAR
CarboplatinEtoposide RFT, LFT, RBS,CBC,CECT CODE OF THE
100mg/m2 D1 - /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
D3Carboplatin AUC 5-6 D1 report,Clinical notes with CBC, RFT, LFT, S.
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
646 MO MO024 CT for CA Head & Neck Etoposide + MO024H MO024H1 S 10200 Y N Blood investigations- CBC, Barcode of drugs used,BAR
CisplatinEtoposide RFT, LFT, RBS,CBC,CECT CODE OF THE
100mg/m2 D1 - D3Cisplatin /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
75-100 mg/m2 D1 every 21 report,Clinical notes with CBC, RFT, LFT, S.
days complete history, risk factors, Creatinine,CHARTS OF
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
647 MO MO024 CT for CA Head & Neck GemcitabineGemcitabine MO024I MO024I1 S 9900 Y N Blood investigations- CBC, Barcode of drugs used,BAR
1000 mg/m2 D1 D8 every RFT, LFT, RBS,CBC,CECT CODE OF THE
21 days /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
648 MO MO024 CT for CA Head & Neck Gemcitabine + MO024J MO024J1 S 13400 Y N Blood investigations- CBC, Barcode of drugs used,BAR
CisplatinGemcitabine 1000 RFT, LFT, RBS,CBC,CECT CODE OF THE
mg/m2 D1 D8Cisplatin 75 /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
mg/m2 D1 every 21 days report,Clinical notes with CBC, RFT, LFT, S.
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
649 MO MO024 CT for CA Head & Neck Paclitaxel + MO024K MO024K1 S 8500 Y N Blood investigations- CBC, Barcode of drugs used,BAR
CarboplatinPaclitaxel RFT, LFT, RBS,CBC,CECT CODE OF THE
80mg/m2 D1Carboplatin /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
AUC 2 D1 every week report,Clinical notes with CBC, RFT, LFT, S.
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
650 MO MO024 CT for CA Head & Neck Paclitaxel + MO024L MO024L1 S 16000 Y N Blood investigations- CBC, Barcode of drugs used,BAR
CarboplatinPaclitaxel RFT, LFT, RBS,CBC,CECT CODE OF THE
175mg/m2 every 21 days /MR face & Neck,Chest X-ray DRUGS,Blood investigations-
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
651 MO MO024 CT for CA Head & Neck PaclitaxelPaclitaxel MO024M MO024M1 S 6600 Y N Blood investigations- CBC, Barcode of drugs used,BAR
80mg/m2 every week RFT, LFT, RBS,CBC,CECT CODE OF THE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
652 MO MO024 CT for CA Head & Neck PaclitaxelPaclitaxel MO024N MO024N1 S 13000 Y N Blood investigations- CBC, Barcode of drugs used,BAR
175mg/m2 every 21 days RFT, LFT, RBS,CBC,CECT CODE OF THE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
653 MO MO024 CT for CA Head & Neck CarboplatinCarboplatin MO024O MO024O1 S 3000 Y N Blood investigations- CBC, Barcode of drugs used,BAR
AUC 2 every week RFT, LFT, RBS,CBC,CECT CODE OF THE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
654 MO MO024 CT for CA Head & Neck CisplatinCisplatin 40mg/m2 MO024P MO024P1 S 2600 Y N Blood investigations- CBC, Barcode of drugs used,BAR
every week RFT, LFT, RBS,CBC,CECT CODE OF THE
DEPARTMENT /
DISCHARGE SUMMARY
OF
DAY CARE DEPA
655 MO MO025 CT for Renal Cell Cancer Sunitinib50 mg once daily 4 MO025A MO025A1 S 11000 Y N 24 hour urine protein,24-hour Bar code of the drugs,BAR
weeks on 2 weeks off urine protein,2 D CODE OF THE
ECHO,Blood investigations: DRUGS,CHARTS OF
CBC, LFT, RFT, RBS; lipid CHEMOTHERAPY
profile, , TFT ,CBC,CECT REGIMEN,Charts of
Thorax, abdomen and chemotherapy regimen,
Pelvis,chest X-ray,Clinical transfusion
notes with documentation of slips,DISCHARGE
relevant SUMMARY OF INPATIENT
history,Histopathology report DEPARTMENT /
,If pseudo tum DISCHARGE SUMMARY
OF DAY CARE
radiology, m
656 MO MO025 CT for Renal Cell Cancer Cabozantinib 60 mg od x 1 MO025B MO025B1 S 14300 Y N 24 hour urine protein,2D BAR CODE OF THE
monthevery 4 weeks ECHO,CBC,LFT,Lipid DRUGS,CHARTS OF
Profile,RBS,RFT,TFT CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
657 MO MO026 CT for Ureter / Bladder / Cisplatin + Methotrexate + MO026A MO026A1 S 7500 Y N Blood investigations- Bar code of the drugs,BAR
Urethra VinblastinMethotrexate CBC,LFT, RFT, CODE OF THE
30mg/m2 D1 D8Vinblastine RBS,CBC,CECT thorax, DRUGS,CHARTS OF
4 mg/m2 D1 D8Doxorubicin abdomen and pelvis ,CECT CHEMOTHERAPY
30 mg/m2 D2Cisplatin 100 Thorax, abdomen and REGIMEN,Charts of
mg/m2 D2Leucovorin 15 Pelvis,Chest X-ray,Clinical chemotherapy regimen,
mg PO D2 D9 every 21 notes with documentation of transfusion
days relevant history,CT-IVU or slips,DISCHARGE
MRU ,cystoscopy + RGP SUMMARY OF INPATIENT
,histopathology,LFT,Metastati DEPARTMENT /
c work-up (Bone sca DISCHARGE SUMMARY
OF DAY CARE
radiology, m
658 MO MO026 CT for Ureter / Bladder / Carboplatin + MO026B MO026B1 S 15300 Y N Blood investigations- Bar code of the drugs,BAR
Urethra GemcitabineGemcitabine CBC,LFT, RFT, CODE OF THE
1000 mg/m2 D1 RBS,CBC,CECT thorax, DRUGS,CHARTS OF
D8Carboplatin AUC 5-6 D1 abdomen and pelvis ,CECT CHEMOTHERAPY
every 21 days Thorax, abdomen and REGIMEN,Charts of
relevant history,CT-IVU or slips,DISCHARGE
OF DAY CARE
radiology, m
659 MO MO026 CT for Ureter / Bladder / Cisplatin + MO026C MO026C1 S 13400 Y N 2D-ECHO,Blood Bar code of the drugs,BAR
Urethra GemcitabineGemcitabine investigations- CBC,LFT, CODE OF THE
1000 mg/m2 D1 RFT, RBS,CBC,CECT thorax, DRUGS,CHARTS OF
D8Cisplatin 75 mg/m2 D1 abdomen and pelvis ,CECT CHEMOTHERAPY
every 21 days Thorax, abdomen and REGIMEN,Charts of
,ECG,histopathology,LFT,Met DEPARTMENT /
astatic work- DISCHARGE SUMMARY
OF DAY CARE
radiology, m
660 MO MO026 CT for Ureter / Bladder / Cisplatin + 5 FU5 FU MO026D MO026D1 S 9000 Y N Blood investigations- Bar code of the drugs,BAR
Urethra 1000mg/m2 D1-D4Cisplatin CBC,LFT, RFT, CODE OF THE
75mg/m2 D1 every 4 weeks RBS,CBC,CECT thorax, DRUGS,CHARTS OF
abdomen and pelvis ,CECT CHEMOTHERAPY
Thorax, abdomen and REGIMEN,Charts of
OF DAY CARE
radiology, m
661 MO MO026 CT for Ureter / Bladder / Cisplatin + MO026E MO026E1 S 14700 Y N Blood investigations- Bar code of the drugs,BAR
Urethra PaclitaxelPaclitaxel 175 mg CBC,LFT, RFT, CODE OF THE
/m2 D1Cisplatin 75 mg /m2 RBS,CBC,CECT thorax, DRUGS,CHARTS OF
D1 every 21 days abdomen and pelvis ,CECT CHEMOTHERAPY
OF DAY CARE
radiology, m
662 MO MO026 CT for Ureter / Bladder / DocetaxelDocetaxel 75 MO026F MO026F1 S 9400 Y N Blood investigations- Bar code of the drugs,BAR
Urethra mg/m2 D1 every 21 days CBC,LFT, RFT, CODE OF THE
RBS,CBC,CECT thorax, DRUGS,CHARTS OF
OF DAY CARE
radiology, m
663 MO MO026 CT for Ureter / Bladder / Gemcitabine + MO026G MO026G1 S 17100 Y N Blood investigations- Bar code of the drugs,BAR
Urethra PaclitaxelGemcitabine 2500 CBC,LFT, RFT, CODE OF THE
mg/m2 D1Paclitaxel 150 RBS,CBC,CECT thorax, DRUGS,CHARTS OF
mg/m2 D1 every 14 days abdomen and pelvis ,CECT CHEMOTHERAPY
OF DAY CARE
radiology, m
664 MO MO026 CT for Ureter / Bladder / GemcitabineGemcitabine MO026H MO026H1 S 9900 Y N Blood investigations- Bar code of the drugs,BAR
Urethra 1000mg /m2 D1 D8 every CBC,LFT, RFT, CODE OF THE
21 days RBS,CBC,CECT thorax, DRUGS,CHARTS OF
OF DAY CARE
radiology, m
665 MO MO026 CT for Ureter / Bladder / Methotrexate + Vinblastin + MO026I MO026I1 S 8300 Y N Blood investigations- Bar code of the drugs,BAR
Urethra Doxorubicin + CBC,LFT, RFT, CODE OF THE
CisplatinMethotrexate RBS,CBC,CECT thorax, DRUGS,CHARTS OF
30mg/m2 D1Vinblastine 3 abdomen and pelvis ,CECT CHEMOTHERAPY
mg/m2 D2Doxorubicin 30 Thorax, abdomen and REGIMEN,Charts of
mg/m2 D2Cuisplatin 70 Pelvis,Chest X-ray,Clinical chemotherapy regimen,
mg/m2 D2 every 14 days notes with documentation of transfusion
,ECG,ECHO,histopathology,L DEPARTMENT /
FT,Metastatic work-up DISCHARGE SUMMARY
OF DAY CARE
radiology, m
666 MO MO026 CT for Ureter / Bladder / Paclitaxel + MO026J MO026J1 S 16000 Y N Blood investigations- Bar code of the drugs,BAR
Urethra CarboplatinPaclitaxel CBC,LFT, RFT, CODE OF THE
175mg/m2 D1Carboplatin RBS,CBC,CECT thorax, DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days abdomen and pelvis ,CECT CHEMOTHERAPY
OF DAY CARE
radiology, m
667 MO MO026 CT for Ureter / Bladder / PaclitaxelPaclitaxel 80 MO026K MO026K1 S 7100 Y N Blood investigations- Bar code of the drugs,BAR
Urethra mg/m2 D1 every week CBC,LFT, RFT, CODE OF THE
RBS,CBC,CECT thorax, DRUGS,CHARTS OF
OF DAY CARE
radiology, m
668 MO MO027 CT for CA Penis Cisplatin + MO027A MO027A1 S 14700 Y N Blood Investigation reports: Bar code of the drugs,BAR
PaclitaxelPaclitaxel 175 CBC, RFT, LFT,CBC,CECT CODE OF THE
mg/m2 D1Cisplatin 75 Thorax, abdomen and DRUGS,CHARTS OF
mg/m2 D1 every 21 days Pelvis,Clinical notes with CHEMOTHERAPY
documentation of relevant REGIMEN,charts of
history,histopathology,Histop chemotherapy regimen,
athology report,LFT,MRI/ CT transfusion
scan (for nodal staging in slips,DISCHARGE
obese, with prior groin SUMMARY OF INPATIENT
surgery and assess pel DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,FNAC report
in cases with palpable/
suspected
669 MO MO027 CT for CA Penis 5 FU + Cisplatin5 FU MO027B MO027B1 S 9000 Y N Blood Investigation reports: Bar code of the drugs,BAR
1000mg/m2 D1-D4Cisplatin CBC, RFT, LFT,CBC,CECT CODE OF THE
75mg/m2 D1 every 4 weeks Thorax, abdomen and DRUGS,CHARTS OF
Pelvis,Clinical notes with CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
suspected
670 MO MO027 CT for CA Penis CapecitabineCapecitabine MO027C MO027C1 S 8100 Y N Blood Investigation reports: Bar code of the drugs,BAR
1000-1250 mg/m2 PO twice CBC, RFT, LFT,CBC,CECT CODE OF THE
daily D1 -D14 every 21 Thorax, abdomen and DRUGS,CHARTS OF
days Pelvis,Clinical notes with CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
suspected
671 MO MO027 CT for CA Penis Paclitaxel + MO027D MO027D1 S 16000 Y N Blood Investigation reports: Bar code of the drugs,BAR
CarboplatinPaclitaxel CBC, RFT, LFT,CBC,CECT CODE OF THE
175mg/m2 D1Carboplatin Thorax, abdomen and DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days Pelvis,Clinical notes with CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
suspected
672 MO MO027 CT for CA Penis PaclitaxelPaclitaxel 80 MO027E MO027E1 S 6600 Y N Blood Investigation reports: Bar code of the drugs,BAR
mg/m2 D1 every week CBC, RFT, LFT,CBC,CECT CODE OF THE
Thorax, abdomen and DRUGS,CHARTS OF
DISCHARGE SUMMARY
OF DAY CARE
suspected
673 MO MO027 CT for CA Penis PaclitaxelPaclitaxel 175 MO027F MO027F1 S 13000 Y N Blood Investigation reports: Bar code of the drugs,BAR
mg/m2 D1 every 21 days CBC, RFT, LFT,CBC,CECT CODE OF THE
Thorax, abdomen and DRUGS,CHARTS OF
DISCHARGE SUMMARY
OF DAY CARE
suspected
674 MO MO027 CT for CA Penis Paclitaxel + MO027G MO027G1 S 8500 Y N Blood Investigation reports: Bar code of the drugs,BAR
CarboplatinPaclitaxel 80 CBC, RFT, LFT,CBC,CECT CODE OF THE
mg/m2 D1Carboplatin AUC Thorax, abdomen and DRUGS,CHARTS OF
2 D1 every week Pelvis,Clinical notes with CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
suspected
675 MO MO028 CT for CA Prostate DocetaxelDocetaxel 60 MO028A MO028A1 S 8800 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
mg/m2 D1 every 14 days RFT, LFT, Prostate Specific CODE OF THE
Antigen (PSA),BONE DRUGS,CHARTS OF
SCAN,Bone scan in locally CHEMOTHERAPY
advanced prostate cancer REGIMEN,Charts of
(T3b-T4)},CBC,CECTThorax, chemotherapy regimen,
abdomen and Pelvis,CECT- transfusion
Thorax, Abdomen, Pelvis/ slips,DISCHARGE
Transrectal Ultrasound SUMMARY OF INPATIENT
(TRUS)/ MRI pelvis ,Clinical DEPARTMENT /
no DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,Evidence of
Biophosphonates (Zoledronic
Acid)
676 MO MO028 CT for CA Prostate DocetaxelDocetaxel 75 MO028B MO028B1 S 9400 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
mg/m2 D1 every 21 days RFT, LFT, Prostate Specific CODE OF THE
OF DAY CARE
Acid)
677 MO MO028 CT for CA Prostate Etoposide + MO028C MO028C1 S 8500 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
CarboplatinEtoposide RFT, LFT, Prostate Specific CODE OF THE
100mg/m2 D1 - Antigen (PSA),BONE DRUGS,CHARTS OF
D3Carboplatin AUC 5-6 D1 SCAN,Bone scan in locally CHEMOTHERAPY
every 21 days advanced prostate cancer REGIMEN,Charts of
OF DAY CARE
Acid)
678 MO MO028 CT for CA Prostate LHRH AgonistLeuprolide MO028D MO028D1 S 16900 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
22.5 ug every 3 months RFT, LFT, Prostate Specific CODE OF THE
OF DAY CARE
Acid)
679 MO MO028 CT for CA Prostate Mitoxantrone + MO028E MO028E1 S 4700 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
PrednisoloneMitoxantrone RFT, LFT, Prostate Specific CODE OF THE
12mg/m2 every 3 Antigen (PSA),BONE DRUGS,CHARTS OF
weeksPrednsiolone 10 mg SCAN,Bone scan in locally CHEMOTHERAPY
daily advanced prostate cancer REGIMEN,Charts of
OF DAY CARE
Acid)
680 MO MO028 CT for CA Prostate Paclitaxel + MO028F MO028F1 S 8500 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
CarboplatinPaclitaxel RFT, LFT, Prostate Specific CODE OF THE
80mg/m2 D1Carboplatin Antigen (PSA),BONE DRUGS,CHARTS OF
AUC 2 D1 every week SCAN,Bone scan in locally CHEMOTHERAPY
OF DAY CARE
Acid)
681 MO MO028 CT for CA Prostate Paclitaxel + MO028G MO028G1 S 16000 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
CarboplatinPaclitaxel RFT, LFT, Prostate Specific CODE OF THE
175mg/m2 D1Carboplatin Antigen (PSA),BONE DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days SCAN,Bone scan in locally CHEMOTHERAPY
OF DAY CARE
Acid)
682 MO MO028 CT for CA Prostate DocetaxelDocetaxel MO028H MO028H1 S 3600 Y N Blood Investigations: CBC, Bar code of the drugs,BAR
20mg/m2 D1 every week RFT, LFT, Prostate Specific CODE OF THE
OF DAY CARE
Acid)
683 MO MO028 CT for CA Prostate Abiraterone 1000 mg + MO028I MO028I1 S 14300 Y N BONE SCAN,CBC,CECT BAR CODE OF THE
Prednisolone 10mg daily Thorax, abdomen and DRUGS,CHARTS OF
Once every month Pelvis,ECG,histopathology,L CHEMOTHERAPY
FT,PSA,RFT REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
684 MO MO029 CT for B - Cell NHL - High Rituximab + MO029A MO029A1 S 28900 Y N 2D Bar code of the drugs,BAR
Grade Cyclophosphamide + ECHO,Biochemistry,Biopsy CODE OF THE
(Except Burkitt's & PCNSL) Etoposide + or fluid flow/PB DRUGS,CHARTS OF
PrednsioloneRituximab cytometry,Biopsy report,Bone CHEMOTHERAPY
375mg/m2Cyclophosphami marrow studies,CBC,CBC, REGIMEN,Charts of
de 750 mg/m2Vincristine LFT, RFT, Viral markers . chemotherapy regimen,
1.4 mg/m2, on HbsAg , HCV and HIV,CECT transfusion
Day1Etoposide 65mg/m2 (chest +abdomen +Pelvis) or slips,DISCHARGE
Day 1 to 3Prednisolone 100 PET-CT,Clinical notes with SUMMARY OF INPATIENT
mg Day 5Total 6 cycles, evidence to support DEPARTMENT /
repeat 21 days indication for therapy, stage o DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
685 MO MO029 CT for B - Cell NHL - High Rituximab + MO029B MO029B1 S 29700 Y N 2D Bar code of the drugs,BAR
Grade Cyclophosphamide + ECHO,Biochemistry,Biopsy CODE OF THE
(Except Burkitt's & PCNSL) Doxorubicin + or fluid flow/PB DRUGS,CHARTS OF
PrednsioloneRituximab cytometry,Biopsy report,Bone CHEMOTHERAPY
375mg/m2Cyclophosphami marrow studies,CBC,CBC, REGIMEN,Charts of
de 750 mg/m2Doxorubicin LFT, RFT, Viral markers . chemotherapy regimen,
50mg/m2Vincristine 1.4 HbsAg , HCV and HIV,CECT transfusion
mg/m2 on (chest +abdomen +Pelvis) or slips,DISCHARGE
Day1Prednisolone 100 mg PET-CT,Clinical notes with SUMMARY OF INPATIENT
Day 5Total 6 cycles, repeat evidence to support DEPARTMENT /
21 days indication for therapy, stage o DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
686 MO MO030 CT for High - Grade NHL - Rituxmab + MO030A MO030A1 S 38400 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
B Cell Dexamethasone + High flow cytometry,Biopsy CODE OF THE
Dose Cytarabine + report,Bone marrow DRUGS,CHARTS OF
CisplatinRituximab studies,CBC,CBC, LFT, RFT, CHEMOTHERAPY
375mg/m2 Day 1Cytarabine Viral markers . HbsAg , HCV REGIMEN,Charts of
2g/m2 BD on day and HIV,CECT (chest chemotherapy regimen,
2Dexamethasone 40 mg +abdomen +Pelvis) or PET- transfusion
Day 1 - 4Cisplatin 75mg/m2 CT,Clinical notes with slips,DISCHARGE
or Carboplatin AUC-5 on evidence to support SUMMARY OF INPATIENT
day 1Cycle to be repeated indication for therapy, stage DEPARTMENT /
every 21days of disease, DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
687 MO MO031 CT for Relapsed B - Cell GDP - RRituximab MO031A MO031A1 S 38900 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
NHL - High Grade 375mg/m2 Day flow cytometry,Biopsy report CODE OF THE
(Except Burkitt's & PCNSL) 1Gemcitabine 1000mg/m2 documenting the relapse of DRUGS,CHARTS OF
on day 1 and HL or NHL and subtype,Bone CHEMOTHERAPY
8Dexamethasone 40 mg marrow studies,CBC,CBC, REGIMEN,Charts of
Day 1 - 4Cisplatin 75mg/m2 LFT, RFT, Viral markers . chemotherapy regimen,
on day 1Cycle to be HbsAg , HCV and HIV,CECT transfusion
repeated every 21daysTotal- (chest +abdomen +Pelvis) or slips,DISCHARGE
6 cycles PET-CT report,Clinical notes SUMMARY OF INPATIENT
with perfor DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
688 MO MO031 CT for Relapsed B - Cell ICE - RRituximab MO031B MO031B1 S 35100 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
NHL - High Grade 375mg/m2Ifosfamide flow cytometry,Biopsy report CODE OF THE
(Except Burkitt's & PCNSL) 1.66g/m2 on day 1 - documenting the relapse of DRUGS,CHARTS OF
3Mesna 1.66g/m2 day 1 - HL or NHL and subtype,Bone CHEMOTHERAPY
3Carboplatin AUC 5 on day marrow studies,CBC,CBC, REGIMEN,Charts of
1Etoposide 100mg/m2 on LFT, RFT, Viral markers . chemotherapy regimen,
day 1 - 3Cycle every HbsAg , HCV and HIV,CECT transfusion
21days for 6 cycles (chest +abdomen +Pelvis) or slips,DISCHARGE
PET-CT report,Clinical notes SUMMARY OF INPATIENT
with perfor DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
689 MO MO032 CT for PMBCL / Burkitt's Etoposide + Prednsiolone + MO032A MO032A1 S 34900 Y N 2D Bar code of the drugs,BAR
Lymphoma / Seropositive Vincristine + ECHO,Biochemistry,Biopsy CODE OF THE
B - Cell NHLR Cyclophosphamide + or bone marrow or peripheral DRUGS,CHARTS OF
DoxorubicinRituximab blood flow cytometry CHEMOTHERAPY
375mg/m2 Day 1Etoposide report,Biopsy or fluid flow REGIMEN,Charts of
50mg/m2VCR cytometry,Bone marrow chemotherapy regimen,
0.4mg/m2Doxorubicin studies,CBC,CBC, LFT, RFT, transfusion
10mg/m2 Day1 - Viral markers . HbsAg , HCV slips,DISCHARGE
4Cyclophosphamide and HIV,CECT (chest SUMMARY OF INPATIENT
750mg/m2 on day 5 +abdomen +Pelvis) or PET- DEPARTMENT /
Prednisolone 100 mg day CT,Clinical notes with evid DISCHARGE SUMMARY
5Every 21 daysDose OF DAY CARE
adjustment each cycle dep DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
690 MO MO033 CT for Burkitt's NHL Codox - M - IVAC- MO033A MO033A1 S 38000 Y N 2D Bar code of the drugs,BAR
cyclophosphamide, ECHO,Biochemistry,Biopsy CODE OF THE
vincristine, doxorubicin, or bone marrow or peripheral DRUGS,CHARTS OF
high-dose methotrexate / blood flow cytometry CHEMOTHERAPY
ifosfamide, etoposide, high- report,Biopsy or fluid flow REGIMEN,Charts of
dose cytarabine)GMALL cytometry,Bone marrow chemotherapy regimen,
(German multicenter acute studies,CBC,CBC, LFT, RFT, transfusion
lymphoblastic Viral markers . HbsAg , HCV slips,DISCHARGE
leukemia)Berlin- Frankfurt - and HIV,CECT (chest SUMMARY OF INPATIENT
MunsterHyper CVAD +abdomen +Pelvis) or PET- DEPARTMENT /
(cyclophosphamide, CT,Clinical notes with evid DISCHARGE SUMMARY
Vincristine, OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
691 MO MO034 CT for Low Grade B - Cell Bendamustine + MO034A MO034A1 S 27500 Y N Biochemistry,Biopsy or bone Bar code of the drugs,BAR
NHL RituximabBendamustine marrow or peripheral blood CODE OF THE
90mg/m2 on day 1, flow cytometry report,Biopsy DRUGS,CHARTS OF
2Rituximab 375mg/m2 on or fluid flow cytometry,Bone CHEMOTHERAPY
day 1Repeat every 28 days, marrow studies,CBC,CBC, REGIMEN,Charts of
Total 6 cycles LFT, RFT, Viral markers . chemotherapy regimen,
HbsAg , HCV and HIV,CECT transfusion
(chest +abdomen +Pelvis) or slips,DISCHARGE
PET-CT,Clinical notes . SUMMARY OF INPATIENT
Performance sta DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
692 MO MO034 CT for Low Grade B - Cell Lenalidomide + MO034B MO034B1 S 24800 Y N Biochemistry,Biopsy or bone Bar code of the drugs,BAR
NHL RituximabRituximab marrow or peripheral blood CODE OF THE
375mg/m2 Day flow cytometry report,Biopsy DRUGS,CHARTS OF
1Lenlidomide 25 mg D1-28, or fluid flow cytometry,Bone CHEMOTHERAPY
for 8 cycles marrow studies,CBC,CBC, REGIMEN,Charts of
LFT, RFT, Viral markers . chemotherapy regimen,
(chest +abdomen +Pelvis) or slips,DISCHARGE
PET-CT,Clinical notes . SUMMARY OF INPATIENT
Performance sta DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
693 MO MO035 CT for Low Grade NHL RituximabRituximab MO035A MO035A1 S 17600 Y N Biochemistry,Biopsy or bone Bar code of the drugs,BAR
375mg/m2 per week for 6 marrow or peripheral blood CODE OF THE
weeks flow cytometry report,Biopsy DRUGS,CHARTS OF
or fluid flow cytometry,Bone CHEMOTHERAPY
marrow studies,CBC,CBC, REGIMEN,Charts of
LFT, RFT, Viral markers . chemotherapy regimen,
Chest abdomen and slips,DISCHARGE
pelvis,CECT (chest SUMMARY OF INPATIENT
+abdomen +Pelvis) or PET- DEPARTMENT /
CT,Cl DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
694 MO MO035 CT for Low Grade NHL Rituximab + MO035B MO035B1 S 19300 Y N Biochemistry,Biopsy or bone Bar code of the drugs,BAR
Cyclophosphamide + marrow or peripheral blood CODE OF THE
Vincristine + flow cytometry report,Biopsy DRUGS,CHARTS OF
PrednisoloneRituximab 375 or fluid flow cytometry,Bone CHEMOTHERAPY
mg/m2Cyclophosphamide marrow studies,CBC,CBC, REGIMEN,Charts of
750mg/m2Vincristine LFT, RFT, Viral markers . chemotherapy regimen,
1.4mg/m2 Day HbsAg , HCV and HIV,CECT transfusion
1Prednisolone 100 mg Day Chest abdomen and slips,DISCHARGE
1 - 5Repeat every 21days. pelvis,CECT (chest SUMMARY OF INPATIENT
Total 6 cycles +abdomen +Pelvis) or PET- DEPARTMENT /
CT,Cl DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
695 MO MO036 CT for Chronic Lymphocytic Fludarabine + MO036A MO036A1 S 20000 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
Leukemia CyclophosphamideFludarab flow cytometry,Bone marrow CODE OF THE
ine 25mg/m2 D1- studies,CBC,Chest X DRUGS,CHARTS OF
3Cyclophosphamide 250 ray,Clinical notes . CHEMOTHERAPY
mg/m2 D1-3 every 28 days Performance status, REGIMEN,Charts of
for 6 cycles PREsence or absence of B chemotherapy regimen,
symptoms, lymphadenopathy transfusion
with size, splenomegaly with slips,DISCHARGE
size comorbidities and SUMMARY OF INPATIENT
indication for therapy, Prior DEPARTMENT /
treat DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
696 MO MO036 CT for Chronic Lymphocytic Rituxmab + MO036B MO036B1 S 18900 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
Leukemia ChlorambucilRituximab flow cytometry,Bone marrow CODE OF THE
375mg/m2 Day studies,CBC,Chest X DRUGS,CHARTS OF
1Chlorambucil 10 mg/m2 ray,Clinical notes . CHEMOTHERAPY
D1-7Repeat every 28 days Performance status, REGIMEN,Charts of
for 12 cycles PREsence or absence of B chemotherapy regimen,
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
697 MO MO036 CT for Chronic Lymphocytic Rituximab + Fludarabine + MO036C MO036C1 S 44800 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
Leukemia CyclophosphamideRituxima flow cytometry,Bone marrow CODE OF THE
b 375mg/m2 on day studies,CBC,Chest X DRUGS,CHARTS OF
1Fludarabine 25mg/m2 D1 - ray,Clinical notes . CHEMOTHERAPY
3Cyclophosphamide 250 Performance status, REGIMEN,Charts of
mg/m2 D1 - 3Every 28 days PREsence or absence of B chemotherapy regimen,
for 6 cycles symptoms, lymphadenopathy transfusion
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
698 MO MO036 CT for Chronic Lymphocytic Lenalidomidelenalidomide- MO036D MO036D1 S 5300 Y N Biochemistry,Biopsy or fluid Bar code of the drugs,BAR
Leukemia 10-25 mg/day day 1 to 21 flow cytometry,Bone marrow CODE OF THE
every 28 days studies,CBC,Chest X DRUGS,CHARTS OF
ray,Clinical notes . CHEMOTHERAPY
Performance status, REGIMEN,Charts of
PREsence or absence of B chemotherapy regimen,
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
699 MO MO037 CT for Peripheral T - Cell CHOEPCyclophosphamide MO037A MO037A1 S 5800 Y N Biochemistry,Biopsy,Bone Bar code of the drugs,BAR
Lymphoma 750mg/m2 D1Vincristine marrow studies,CBC,CBC, CODE OF THE
1.4mg/m2 D1Adriamycin 50 LFT, RFT, Viral markers . DRUGS,CHARTS OF
mg/m2 D1Etoposide HbsAg , HCV and HIV,CECT CHEMOTHERAPY
100mg/m2 D1- (chest +abdomen +Pelvis) or REGIMEN,Charts of
3Prednisolone 100 mg PET-CT,Clinical notes with chemotherapy regimen,
D5Every 21days. Total 6 evidence to support transfusion
cycles indication for therapy, stage slips,DISCHARGE
of disease, performance SUMMARY OF INPATIENT
status and disease sites i DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
700 MO MO037 CT for Peripheral T - Cell CHOPCyclophosphamide MO037B MO037B1 S 5700 Y N Biochemistry,Biopsy,Bone Bar code of the drugs,BAR
Lymphoma 750mg/m2 D1Vincristine marrow studies,CBC,CBC, CODE OF THE
1.4mg/m2 D1Adriamycin 50 LFT, RFT, Viral markers . DRUGS,CHARTS OF
mg/m2 D1Prednisolone 100 HbsAg , HCV and HIV,CECT CHEMOTHERAPY
mg D5Every 21days. Total (chest +abdomen +Pelvis) or REGIMEN,Charts of
6 cycles PET-CT,Clinical notes with chemotherapy regimen,
evidence to support transfusion
indication for therapy, stage slips,DISCHARGE
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
701 MO MO037 CT for Peripheral T - Cell SMILEMethotrexate MO037C MO037C1 S 21700 Y N Biochemistry,Biopsy,Bone Bar code of the drugs,BAR
Lymphoma 2gm/m2 D1Ifosfamide marrow studies,CBC,CBC, CODE OF THE
1500mg/m2 D2-4Etoposide LFT, RFT, Viral markers . DRUGS,CHARTS OF
100mg/m2 D2-4L- HbsAg , HCV and HIV,CECT CHEMOTHERAPY
asparginase 6000U/m2 (chest +abdomen +Pelvis) or REGIMEN,Charts of
D8,10,12,14,16,18,20Dexa PET-CT,Clinical notes with chemotherapy regimen,
methasone 40mg D1-4 evidence to support transfusion
every 28 days indication for therapy, stage slips,DISCHARGE
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
702 MO MO038 CT for NK - T Cell GELOXGemcitabine MO038A MO038A1 S 21300 Y N Biochemistry,Biopsy,Bone Bar code of the drugs,BAR
Lymphoma 1000mg/m2 D1 and marrow studies,CBC,CBC, CODE OF THE
D8Oxaliplatin 130mg/m2 LFT, RFT, Viral markers . DRUGS,CHARTS OF
D1L- asparginase 6000 HbsAg , HCV and HIV,CECT CHEMOTHERAPY
U/m2 D1-7Repeat every 21 (chest +abdomen +Pelvis) or REGIMEN,Charts of
days PET-CT,Clinical notes with chemotherapy regimen,
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
703 MO MO038 CT for NK - T Cell LVPL-asparginase MO038B MO038B1 S 8800 Y N Biochemistry,Biopsy,Bone Bar code of the drugs,BAR
Lymphoma 6000U/m2 D5Vincristine marrow studies,CBC,CBC, CODE OF THE
1.4mg/m2 D1Prednisolone LFT, RFT, Viral markers . DRUGS,CHARTS OF
100mg D5Repeat every 21 HbsAg , HCV and HIV,CECT CHEMOTHERAPY
days (chest +abdomen +Pelvis) or REGIMEN,Charts of
PET-CT,Clinical notes with chemotherapy regimen,
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
704 MO MO039 CT for Hodgkin's COPPCyclophosphamide MO039A MO039A1 S 4300 Y N 2D- Bar code of the drugs,BAR
Lymphoma 650mg/m2 D1, 8Vincristine ECHO,Biochemistry,Biopsy CODE OF THE
1.4mg/m2 D1, to confirm diagnosis of HL DRUGS,CHARTS OF
8Procarbazine 100 mg/m2 ,Bone marrow CHEMOTHERAPY
D1-14Prednisolone studies,CBC,CBC, ESR, REGIMEN,Charts of
40mg/m2 D1-14Every LFT,RFT,Clinical notes with chemotherapy regimen with
28days. Total 6 - 8 cycles Indications, history, dates and dose, transfusion
Performance status, Stage, slips,DISCHARGE
Age, comorbidities, any prior SUMMARY OF INPATIENT
chemotherapy and response DEPARTMENT /
to it,node Biopsy,PET CT or DISCHARGE SUMMARY
CECT OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS (PAT
705 MO MO039 CT for Hodgkin's ABVDAdriamycin MO039B MO039B1 S 11300 Y N 2D-ECHO (repeated after Bar code of the drugs,BAR
Lymphoma 25mg/m2Bleomycin cycle 4 ),Biochemistry,Biopsy CODE OF THE
10unit/m2Vinblastine to confirm diagnosis of HL DRUGS,CHARTS OF
6mg/m2Dacarbazine 375 ,Bone marrow CHEMOTHERAPY
mg/m2 Day 1,15Every 28 studies,CBC,CBC, ESR, REGIMEN,Charts of
days for 6 cycles LFT,RFT,Clinical notes with chemotherapy regimen with
Indications, history, dates and dose, transfusion
to it, DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS (PAT
706 MO MO039 CT for Hodgkin's AEVDAdriamycin MO039C MO039C1 S 11300 Y N 2D-ECHO (repeated after Bar code of the drugs,BAR
Lymphoma 25mg/m2Vinblastine cycle 4 ),Biochemistry,Biopsy CODE OF THE
6mg/m2Dacarbazine 375 to confirm diagnosis of HL DRUGS,CHARTS OF
mg/m2 Day 1,15Etoposide ,Bone marrow CHEMOTHERAPY
65mg/m2 Day 1-3, 15- studies,CBC,CBC, ESR, REGIMEN,Charts of
17Every 28 days for 6 LFT,RFT,Clinical notes with chemotherapy regimen with
cycles Indications, history, dates and dose, transfusion
to it, DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS (PAT
707 MO MO040 CT for Relapsed Hodgkin ICEIfosfamide 1.5 mg/m2 MO040A MO040A1 S 11600 Y N Biochemistry,Biopsy,Biopsy Bar code of the drugs,BAR
Lymphoma D1-3Carboplatin AUC5 report documenting the CODE OF THE
D2Etoposide 100mg/m2 D1- relapse of HL or NHL and DRUGS,CHARTS OF
3Every 3 weeks subtype,Bone marrow CHEMOTHERAPY
studies,CBC,CBC, LFT, RFT, REGIMEN,Charts of
Viral markers . HbsAg , HCV chemotherapy regimen,
and HIV,CECT (chest transfusion
+abdomen +Pelvis) or PET- slips,DISCHARGE
CT report,Clinical notes with SUMMARY OF INPATIENT
performance status and DEPARTMENT /
disease DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
708 MO MO040 CT for Relapsed Hodgkin MINEIfosfamide 4 gm/m2 MO040B MO040B1 S 11600 Y N Biochemistry,Biopsy,Biopsy Bar code of the drugs,BAR
Lymphoma over 3days (D1- report documenting the CODE OF THE
3)Mitoxantrone relapse of HL or NHL and DRUGS,CHARTS OF
8mg/m2Etoposide subtype,Bone marrow CHEMOTHERAPY
65mg/m2 D1-3Every 3 studies,CBC,CBC, LFT, RFT, REGIMEN,Charts of
weeks Viral markers . HbsAg , HCV chemotherapy regimen,
and HIV,CECT (chest transfusion
+abdomen +Pelvis) or PET- slips,DISCHARGE
CT report,Clinical notes with SUMMARY OF INPATIENT
performance status and DEPARTMENT /
disease DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
709 MO MO040 CT for Relapsed Hodgkin PTCL - GDPGemcitabine MO040C MO040C1 S 16300 Y N Biochemistry,Biopsy report Bar code of the drugs,BAR
Lymphoma 1000mg/m2 D1 and documenting the relapse of CODE OF THE
D8Dexamethasone 40mg HL or NHL and subtype,Bone DRUGS,CHARTS OF
D1-4Cisplatin 75mg/m2 D1 marrow studies,CBC,CBC, CHEMOTHERAPY
orCacrboplatin AUC-5Every LFT, RFT, Viral markers . REGIMEN,Charts of
3 weeks HbsAg , HCV and HIV,CECT chemotherapy regimen,
(chest +abdomen +Pelvis) or transfusion
PET-CT report,Clinical notes slips,DISCHARGE
with performance status and SUMMARY OF INPATIENT
disease sites DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
710 MO MO041 CT for Relapsed NHL & HL DHAPDexamethasone MO041A MO041A1 S 13800 Y N Biochemistry,Biopsy report Bar code of the drugs,BAR
40mg D1-4Cisplatin documenting the relapse of CODE OF THE
100mg/m2 or Carboplatin HL or NHL and subtype,Bone DRUGS,CHARTS OF
AUC-5D1Cytarabine 2 marrow studies,CBC,CBC, CHEMOTHERAPY
gm/m2 BD D2Repeat every LFT, RFT, Viral markers . REGIMEN,Charts of
21 days HbsAg , HCV and HIV,CECT chemotherapy regimen,
(chest +abdomen +Pelvis) or transfusion
PET-CT report,Clinical notes slips,DISCHARGE
with performance status and SUMMARY OF INPATIENT
disease sites DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
711 MO MO042 CT for MM / Amyloidosis / Lenalidomide + MO042A MO042A1 S 5800 Y N Biochemistry,Blood Bar code of the drugs,BAR
POEMS DexamethasoneLenalidomi Investigations such as CBC, CODE OF THE
de 25 mg daily Day1- LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
21Dexamethasone 40mg (HBsAg, HCV, HIV), CHEMOTHERAPY
Day 1, 8, 15, 22Every calculated creatinine REGIMEN,Charts of
28days clearance, Beta2 chemotherapy regimen,
microglobulin, SPEP+IFE, transfusion
S.FLC assay, Urine Bence slips,DISCHARGE
Jones Protein (BJP) ( may SUMMARY OF INPATIENT
not be done if SPEP and FLC DEPARTMENT /
assay show M band DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
712 MO MO042 CT for MM / Amyloidosis / Pomalidomide + MO042B MO042B1 S 7900 Y N Biochemistry,Blood Bar code of the drugs,BAR
POEMS DexamethasonePomalidom Investigations such as CBC, CODE OF THE
ide 4 mg daily Day 1- LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
21Dexamethasone 40mg (HBsAg, HCV, HIV), CHEMOTHERAPY
Day 1, 8, 15, 22Every 28 calculated creatinine REGIMEN,Charts of
days clearance, Beta2 chemotherapy regimen,
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
713 MO MO043 CT for MM / Amyloidosis Cyclophosphamide + MO043A MO043A1 S 4500 Y N Biochemistry,Blood Bar code of the drugs,BAR
Thalidomide + Investigations such as CBC, CODE OF THE
DexamethasoneCyclophosp LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
hamide 100mg D1- (HBsAg, HCV, HIV), CHEMOTHERAPY
D14Thalidomide 100-200 calculated creatinine REGIMEN,Charts of
mg daily Day 1- clearance, Beta2 chemotherapy regimen,
28Dexamethasone 40mg microglobulin, SPEP+IFE, transfusion
Day 1, 8, 15, 22Every 28 S.FLC assay, Urine Bence slips,DISCHARGE
days Jones Protein (BJP) ( may SUMMARY OF INPATIENT
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
714 MO MO043 CT for MM / Amyloidosis Melphalan + Thalidomide + MO043B MO043B1 S 4600 Y N Biochemistry,Blood Bar code of the drugs,BAR
PrednisoloneMelphalan Investigations such as CBC, CODE OF THE
9mg/m2 D1-D4Thalidomide LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
100mg D1-28Prednisolone (HBsAg, HCV, HIV), CHEMOTHERAPY
100mg Day1-4Every calculated creatinine REGIMEN,Charts of
28days clearance, Beta2 chemotherapy regimen,
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
715 MO MO043 CT for MM / Amyloidosis Bortezomib + MO043C MO043C1 S 16100 Y N Biochemistry,Blood Bar code of the drugs,BAR
Cyclophosphamide + Investigations such as CBC, CODE OF THE
Dexamethasone LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
Cyclophosp hamide - 300 (HBsAg, HCV, HIV), CHEMOTHERAPY
mg/m2 day 1, calculated creatinine REGIMEN,Charts of
8, 15, 22Dexamethasone clearance, Beta2 chemotherapy regimen,
40mg Day 1, 8, 15, microglobulin, SPEP+IFE, transfusion
22Bortezomib 1.3 mg/m2 S.FLC assay, Urine Bence slips,DISCHARGE
Day1, 8, 15, 22Every 28 Jones Protein (BJP) ( may SUMMARY OF INPATIENT
days not be done if SPEP and FLC DEPARTMENT /
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
716 MO MO043 CT for MM / Amyloidosis Bortezomib + MO043D MO043D1 S 14700 Y N Biochemistry,Blood Bar code of the drugs,BAR
Dexamethasone Investigations such as CBC, CODE OF THE
Bortezomib 1.3 mg/m2 LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
Day1, 8, 15, (HBsAg, HCV, HIV), CHEMOTHERAPY
22Dexamethasone 40mg calculated creatinine REGIMEN,Charts of
Day1, 8, 15, 22Every 28 clearance, Beta2 chemotherapy regimen,
day microglobulin, SPEP+IFE, transfusion
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
717 MO MO043 CT for MM / Amyloidosis Bortezomib + Melphalan + MO043E MO043E1 S 13900 Y N Biochemistry,Blood Bar code of the drugs,BAR
Prednsiolone Melphalan Investigations such as CBC, CODE OF THE
9mg/m2 D1- LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
D4Prednisolone 100mg (HBsAg, HCV, HIV), CHEMOTHERAPY
Day 1-4Bortezomib 1.3 calculated creatinine REGIMEN,Charts of
mg/m2 Day 1, 8, 15, clearance, Beta2 chemotherapy regimen,
22Every 28 days microglobulin, SPEP+IFE, transfusion
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
718 MO MO043 CT for MM / Amyloidosis Bortezomib + Lenalidomide MO043F MO043F1 S 19600 Y N Biochemistry,Blood Bar code of the drugs,BAR
+ Investigations such as CBC, CODE OF THE
Dexamethasone LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
Lenalidomi de 25 mg daily (HBsAg, HCV, HIV), CHEMOTHERAPY
Day 1 - 21Dexamethasone calculated creatinine REGIMEN,Charts of
40mg Day 1, 8, 15, clearance, Beta2 chemotherapy regimen,
22Bortezomib microglobulin, SPEP+IFE, transfusion
1.3 mg/m2 Day 1, 8, 15, S.FLC assay, Urine Bence slips,DISCHARGE
22Every 28 days Jones Protein (BJP) ( may SUMMARY OF INPATIENT
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
719 MO MO043 CT for MM / Amyloidosis Bortezomib + Thalidomide MO043G MO043G1 S 16500 Y N Biochemistry,Blood Bar code of the drugs,BAR
+ Investigations such as CBC, CODE OF THE
Dexamethasone Thalidomid LFT, RFT, Ca, Viral markers DRUGS,CHARTS OF
e 100 mg daily Day 1 - 28 (HBsAg, HCV, HIV), CHEMOTHERAPY
Dexamethasone 40 mg Day calculated creatinine REGIMEN,Charts of
1, 8, 15, 22Bortezomib 1.3 clearance, Beta2 chemotherapy regimen,
mg/m2 Day 1, 8, 15, microglobulin, SPEP+IFE, transfusion
22Every 28 days S.FLC assay, Urine Bence slips,DISCHARGE
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
720 MO MO044 CT for Chronic Myeloid Imatinib Imatinib 400 mg, MO044A MO044A1 S 16500 Y N Biopsy,BONE Bar code of the drugs,BAR
Leukemia 600 mg, 800 mg(per month MARROW,Bone marrow CODE OF THE
X 5 years) aspiration and biopsy (if DRUGS,CHARTS OF
done), Conventional CHEMOTHERAPY
cytogenetics or FISH on bone REGIMEN,Charts of
marrow or RT-PCR on chemotherapy regimen,
peripheral blood or bone transfusion
marrow,CBC,CBC, Peripheral slips,DISCHARGE
smear, LFT, RFT,Clinical SUMMARY OF INPATIENT
notes with mention of prior DEPARTMENT /
treatment if any with re DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
721 MO MO044 CT for Chronic Myeloid Dasatinib 100 mg once a MO044B MO044B1 S 5500 Y N Biopsy,BONE BAR CODE OF THE
Leukemia day MARROW,CBC,CYTOGENE DRUGS,CHARTS OF
TICS,LFT,MDC,RFT,RQ PCR CHEMOTHERAPY
BCR ABL REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
722 MO MO045 CT for Myeloproliferative Hydroxurea Hydroxurea MO045A MO045A1 S 2500 Y N 2D ECHO or NCCT Chest/ Bar code of the drugs,BAR
Neoplasm daily(Dose will be based on CECT Chest, Abdomen and CODE OF THE
blood counts) Pelvis.,Admission/ clinical DRUGS,Charts of
notes with complete history, chemotherapy regimen
physical examinations, ,CHARTS OF
indications and plan of CHEMOTHERAPY
treatment.,Biochemistry REGIMEN,DISCHARGE
(RBS, LFT, RFT, LDH, SE, SUMMARY OF INPATIENT
Ca, PO4) ,BONE DEPARTMENT /
MARROW,Bone marrow DISCHARGE SUMMARY
aspiration/ biopsy an OF DAY CARE
hemat
723 MO MO046 CT for Acute Myeloid Cytarabine 2 gm / M2 BD MO046A MO046A1 S 78400 Y N Blood tests including Barcode of the drugs ,BAR
Leukemia for 5Every 21 days for 3 Complete blood counts, renal CODE OF THE
cycles function tests, liver function DRUGS,CHARTS OF
tests,Bone marrow CHEMOTHERAPY
aspiration,Bone marrow REGIMEN,Charts of
report confirming complete chemotherapy regimen,
remission after induction transfusion
(typically done on day 21-28 slips,DISCHARGE
after the start date of SUMMARY OF INPATIENT
induction chemotherapy),CB DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,Periodic CBC
reports (once a week
minimum dur
724 MO MO046 CT for Acute Myeloid Cytarabine 100 mg / M2 7 MO046B MO046B1 S 116200 Y N AML for reinduction cases: Barcode of the drugs ,BAR
Leukemia days Daunomycin 60 mg / Clinical notes stating date of CODE OF THE
M2 3 ( this does not include start of induction therapy DRUGS,CHARTS OF
antibiotics, antifungals, (should be atleast 3 weeks CHEMOTHERAPY
blood and platelets before),AML for reinduction REGIMEN,Charts of
transfusion) cases: Peripheral blood or chemotherapy regimen,
bone marrow showing transfusion
persistent of disease (second slips,DISCHARGE
BM or PB . after day 21 of SUMMARY OF INPATIENT
first BM te DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
minimum dur
725 MO MO047 CT for Acute Lymphoblastic Berlin- Frankfurt -Munster- MO047A MO047A1 S 176000 Y N Biochemistry,Bone marrow BAR CODE OF THE
Leukemia 90, Berlin- Frankfurt - report ,CBC,CBC, LFT, RFT, DRUGS,Barcodes of the
Munster-95, Berlin- random blood sugar, CSF drugs,CHARTS OF
Frankfurt -Munster- cytology report,Clinical notes CHEMOTHERAPY
2000Hyper . Performance status and any REGIMEN,Copy of treatment
(cyclophosphamide, infections, if yes - protocol with dates and
Vincristine, site,Documentation of doses which were delivered
Adriamycin ,Dexamethason induction dates . start and at the end of each
e UKALL (United kingdom end date along with the name month,DISCHARGE
acute of regimen SUMMARY OF INPATIENT
lymphoblasticleukaemia) DEPARTMENT /
GMALL (German DISCHARGE SUMMARY OF
multicenter acute DAY CARE
lymphoblastic DEPARTMENT,R
726 MO MO047 CT for Acute Lymphoblastic Berlin- Frankfurt -Munster- MO047B MO047B1 S 136200 Y N 2D ECHO,Biopsy,BONE BAR CODE OF THE
Leukemia 90Berlin- Frankfurt -Munster MARROW or Peripheral DRUGS,Barcodes of the
95Berlin- Frankfurt -Munster blood FLOW drugs,CHARTS OF
2000Hyper CYTOMETRY,CBC,CBC, CHEMOTHERAPY
(cyclophosphamide, peripheral smear, LFT, RFT, REGIMEN,Copy of treatment
Vincristine, Adriamycin Blood sugar, SE, Ca, Po4, protocol with dates and
,Dexamethasone UKALL 2D-ECHO if age>30 years, doses which were delivered
(United kingdom acute Peripheral blood or Bone at the end of each
lymphoblastic marrow aspiration with month,DISCHARGE
leukaemia)GMALL (German immunophenotyping to SUMMARY OF INPATIENT
multicenter acute confirm the diagnosis as DEPARTMENT /
lymphoblastic leukem ALL,Clinica DISCHARGE SUMMARY OF
DAY CARE
DEPARTMENT,R
727 MO MO047 CT for Acute Lymphoblastic 6 Mercaptopurine 50 mg / MO047C MO047C1 S 4400 Y N Admission Or Clinical BAR CODE OF THE
Leukemia M2 daily Notes,Biochemistry,Biopsy,Bl DRUGS,Barcodes of the
Methotrexate 25 mg / M2 ood investigations- CBC, drugs,CHARTS OF
Weekly for 2 years LFT,RFT,BONE CHEMOTHERAPY
MARROW,CBC,CSF REGIMEN,Copy of treatment
CYTOMORPHOLOGY,CYTO protocol with dates and
GENETICS,Documentation of doses which were delivered
consolidation dates . start at the end of each
and end date along with the month,DISCHARGE
name of SUMMARY OF INPATIENT
regimen,Documentation of DEPARTMENT /
induction dates . DISCHARGE SUMMARY OF
DAY CARE
DEPARTMENT,R
728 MO MO048 CT for Lymphoblastic Berlin- Frankfurt -Munster- MO048A MO048A1 S 176000 Y N Biochemistry,CBC,CBC, LFT, Bar code of the drugs,BAR
Lymphoma 90Berlin- Frankfurt -Munster RFT, Viral markers . HbsAg , CODE OF THE
95Berlin- Frankfurt -Munster HCV and HIV,CECT (chest DRUGS,CHARTS OF
2000Hyper CVAD +abdomen +Pelvis) or PET- CHEMOTHERAPY
(cyclophosphamide, CT,Clinical notes with REGIMEN,Charts of
Vincristine, Adriamycin, evidence to support chemotherapy regimen,
Dexamethasone UKALL indication for therapy, stage transfusion
(United kingdom acute of disease, performance slips,DISCHARGE
lymphoblastic status and disease sites SUMMARY OF INPATIENT
leukaemia)GMALL (German including extranodal sites DEPARTMENT /
multicenter acute DISCHARGE SUMMARY
lymphoblastic OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
729 MO MO048 CT for Lymphoblastic Berlin- Frankfurt -Munster- MO048B MO048B1 S 136200 Y N 2D ECHO,Biopsy,BONE Bar code of the drugs,BAR
Lymphoma 90Berlin- Frankfurt -Munster MARROW or Peripheral CODE OF THE
95 Berlin- Frankfurt - blood FLOW DRUGS,CHARTS OF
Munster-2000Hyper CVAD CYTOMETRY,CBC,CBC, CHEMOTHERAPY
(cyclophosphamide, LFT, RFT, Viral markers . REGIMEN,Charts of
Vincristine, Adriamycin, HbsAg , HCV and HIV,CECT chemotherapy regimen,
Dexamethasone UKALL (chest +abdomen +Pelvis) or transfusion
(United kingdom acute PET-CT,Clinical notes with slips,DISCHARGE
lymphoblastic evidence to support SUMMARY OF INPATIENT
leukaemia)GMALL (German indication for therapy, stage DEPARTMENT /
multicenter acute of disease, performance stat DISCHARGE SUMMARY
lymphoblastic OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
730 MO MO048 CT for Lymphoblastic 6 Mercaptopurine 50 mg/M2 MO048C MO048C1 S 4400 Y N Biochemistry,Biopsy,BONE Bar code of the drugs,BAR
Lymphoma daily and Methotrexate 25 MARROW,CBC,CBC, LFT, CODE OF THE
mg/M2 Weekly for 2 Years RFT, Viral markers . HbsAg , DRUGS,CHARTS OF
HCV and HIV,CECT (chest CHEMOTHERAPY
+abdomen +Pelvis) or PET- REGIMEN,Charts of
CT,Clinical notes with chemotherapy regimen,
status and disease sites DEPARTMENT /
including DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY, M
731 MO MO049 CT for Acute Promyelocytic Arsenic trioxide MO049A MO049A1 S 79200 Y N Biochemistry,BONEMARRO Barcode of the drugs ,BAR
Leukemia ATRA W,CBC,Clinical notes CODE OF THE
(High Risk) Daunomycin or Idarubcin containing patient Age, DRUGS,CHARTS OF
Cytarabine - multiagent - Performance status, CHEMOTHERAPY
vary in each protocol comorbidities, extramedullary REGIMEN,Charts of
disease sites if any; any chemotherapy regimen,
infections, performance transfusion
status,Complete blood slips,DISCHARGE
counts, renal function tests, SUMMARY OF INPATIENT
liver function tests, ECG, DEPARTMENT /
coagulati DISCHARGE SUMMARY
OF DAY CARE
minimum dur
732 MO MO049 CT for Acute Promyelocytic Arsenic trioxide MO049B MO049B1 S 106500 Y N 2D Barcode of the drugs ,BAR
Leukemia ATRADaunomycin or ECHO,APTT,Biochemistry,Bi CODE OF THE
(High Risk) IdarubcinCytarabine - opsy,BONE DRUGS,CHARTS OF
multiagent - vary on MARROW,CBC,Clinical CHEMOTHERAPY
protocol notes containing patient Age, REGIMEN,Charts of
Performance status, chemotherapy regimen,
comorbidities, extramedullary transfusion
disease sites if any; any slips,DISCHARGE
infections, performance SUMMARY OF INPATIENT
status,Complete blood DEPARTMENT /
counts, renal function tests, DISCHARGE SUMMARY
liver function OF DAY CARE
minimum dur
733 MO MO049 CT for Acute Promyelocytic 6 MP 50 mg / day MO049C MO049C1 S 8800 Y N 2D Barcode of the drugs,BAR
Leukemia Daily ECHO,APTT,Biochemistry,Bi CODE OF THE
(High Risk) Methotrexate 15 mg opsy,BONE DRUGS,CHARTS OF
WeeklyATRA 45 mg / M2 MARROW,CBC,Clinical CHEMOTHERAPY
for 14 days Every three notes containing patient Age, REGIMEN,Charts of
months for 18 Months Performance status, chemotherapy regimen,
comorbidities, extramedullary transfusion
disease sites if any; any slips,DISCHARGE
infections, performance SUMMARY OF INPATIENT
status,Complete blood DEPARTMENT /
counts, renal function tests, DISCHARGE SUMMARY
liver function OF DAY CARE
minimum duri
734 MO MO050 CT for Acute Promyelocytic ATO: Arsenic trioxide 0.15 MO050A MO050A1 S 60500 Y N CBC,Clinical notes containing Barcode of the drugs,BAR
Leukemia mg / kg day 1-Day 5, day 8- patient Age, Performance CODE OF THE
(Low Risk) 12, day 15-19, day 22-26 status, comorbidities, DRUGS,CHARTS OF
every 56 days for 4 extramedullary disease sites CHEMOTHERAPY
cyclesATRA : All trans if any; any infections, REGIMEN,Charts of
retinoic acid 45 mg / M2 performance status,Complete chemotherapy regimen,
day 1-Day 14 and Day 29- blood counts, renal function transfusion
43 every 56 days for 4 tests, liver function tests, slips,DISCHARGE
cycles - (per 56 day cycle) ECG, coagulation SUMMARY OF INPATIENT
profile,Documentation DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
minimum duri
735 MO MO050 CT for Acute Promyelocytic ATO: Arsenic trioxide 0.15 MO050B MO050B1 S 89100 Y N Biochemistry,CBC,Clinical Barcode of the drugs ,BAR
Leukemia mg / kg day 1-45 or notes containing patient Age, CODE OF THE
(Low Risk) 60ATRA: All trans retinoic Performance status, DRUGS,CHARTS OF
acid 45 mg / M2 - day 1-45 comorbidities, extramedullary CHEMOTHERAPY
or 60 disease sites if any; any REGIMEN,Charts of
infections, performance chemotherapy regimen,
status,Complete blood transfusion
counts, renal function tests, slips,DISCHARGE
liver function tests, ECG, SUMMARY OF INPATIENT
coagulation profile, DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
minimum dur
736 MO MO051 Febrile Neutopenia Cefoperazone + MO051A MO051A1 S 36600 Y N Biochemistry,BONE Bar code of the drugs ,BAR
SulbactumPiperalicillin + MARROW,CBC,Clinical CODE OF THE
TazobactumCefoperazoneP notes/ Admission notes DRUGS,Charts of
iperacillinAmikacinGentami including Indications, Stage it chemotherapy regimen
cinCefipimeLevofloxacinAm needs to be used, pre/ post- ,CHARTS OF
oxycillin and surgical, along with Radiation CHEMOTHERAPY
clavulanateTeicoplaninVanc therapy, recurrence, REGIMEN,DISCHARGE
omycin etc.,ECG,PML RARA,RQ SUMMARY OF INPATIENT
PCR DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
hema
737 MO MO051 Febrile Neutopenia MeropenemImipenemColisti MO051B MO051B1 S 86700 Y N CBC,Clinical notes/ Bar code of the drugs ,BAR
nTigecyclinLinezolidVoricon Admission notes including CODE OF THE
azoleCaspfunginAmphoteri Indications, Stage it needs to DRUGS,Charts of
cin - B be used, pre/ post- surgical, chemotherapy regimen
along with Radiation therapy, ,CHARTS OF
recurrence, etc.,LFT,PML CHEMOTHERAPY
RARA,RQ PCR REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
hema
738 MO MO052 Chemotherapy RasburicaseFebuxostatAllo MO052A MO052A1 S 26400 Y N Blood Phosphate Bar code of the drugs ,BAR
Complications - Tumor purinolSevelamer levels,BUN,CBC,Clinical CODE OF THE
Lysis Syndrome notes/ Admission notes DRUGS,Charts of
including Indications, Stage it chemotherapy regimen
needs to be used, pre/ post- ,CHARTS OF
surgical, along with Radiation CHEMOTHERAPY
therapy, recurrence, REGIMEN,DISCHARGE
etc.,LFT,Serum SUMMARY OF INPATIENT
Electrolytes,Uric Acid DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
hema
739 MO MO053 Granulocyte Colony 5 microgram / kg / day(max MO053A MO053A1 S 5000 Y N BONE Bar code of the drugs ,BAR
Stimulating Factor Use 300 microgram per day) for MARROW,CBC,Clinical CODE OF THE
7 days orPEG - GCSF 6mg notes/ Admission notes DRUGS,Charts of
one single dose per including Indications, Stage it chemotherapy regimen
chemotherapy cycle needs to be used, pre/ post- ,CHARTS OF
surgical, along with Radiation CHEMOTHERAPY
therapy, recurrence, REGIMEN,DISCHARGE
etc.,LFT,RFT SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
hema
740 MO MO054 CT for Langerhans Cell Langerhans Cell MO054A MO054A1 S 27900 Y N Admission Or Clinical BAR CODE OF THE
Histiocytosis Histiocytosis(Histiocytosis Notes,Biopsy,BONE DRUGS,CHARTS OF
Protocol - Induction) MARROW,CBC,LFT,MDC,R CHEMOTHERAPY
FT,SKELETAL SURVEY OR REGIMEN,DISCHARGE
PET CECT SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
741 MO MO054 CT for Langerhans Cell Langerhans Cell MO054B MO054B1 S 31800 Y N Admission Or Clinical BAR CODE OF THE
Histiocytosis Histiocytosis(Histiocytosis Notes,BONE DRUGS,CHARTS OF
Protocol - Maintenance) MARROW,CBC,LFT,MDC,R CHEMOTHERAPY
FT,SKELETAL SURVEY OR REGIMEN,DISCHARGE
PET CECT SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
742 MO MO055 CT for Low Grade Glioma Vincristine + MO055A MO055A1 S 6500 Y N Admission Or Clinical BAR CODE OF THE
CarboplatinVincristine Notes,Biochemistry,Biopsy,C DRUGS,CHARTS OF
1.5mg/m2 (day 1, 8 and 15 BC,MRI CHEMOTHERAPY
for first 4 cycles and then REGIMEN,DISCHARGE
only day 1 from cycle 5 to SUMMARY OF INPATIENT
17)Carboplatin 550mg/m2 DEPARTMENT /
every 3 weeks (all cycles) DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
743 MO MO055 CT for Low Grade Glioma VinblastinVinblastine 6 MO055B MO055B1 S 3700 Y N Admission Or Clinical BAR CODE OF THE
mg/m2 every week Notes,Biochemistry,Biopsy,C DRUGS,CHARTS OF
BC,MRI CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
744 MO MO056 CT for Medulloblastoma / PACKER MO056A MO056A1 S 7000 Y N Admission Or Clinical BAR CODE OF THE
Brain PNET Notes,Biochemistry,Biopsy,C DRUGS,CHARTS OF
BC,CSF CYTOLOGY,MRI CHEMOTHERAPY
(BRAIN AND SPINE) REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
745 MO MO056 CT for Medulloblastoma / Cisplatin + MO056B MO056B1 S 9200 Y N Admission Or Clinical BAR CODE OF THE
CNS PNET Cyclophosphamide + Notes,Biochemistry,Biopsy,C DRUGS,CHARTS OF
VincristineCyclophosphami BC,CSF CYTOLOGY,MRI CHEMOTHERAPY
de 1000mg/m2 (2 every (BRAIN AND SPINE) REGIMEN,DISCHARGE
cycles)Vincristine 1.5mg/m2 SUMMARY OF INPATIENT
(days 1 and 8)Cisplatin DEPARTMENT /
100mg/m2 (1 day per DISCHARGE SUMMARY
cycle)Cycles given every 3 OF DAY CARE
weekly DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
746 MO MO057 CT for Neuroblastoma Cabroplatin + Etoposide + MO057A MO057A1 S 9500 Y N Admission Or Clinical BAR CODE OF THE
Cyclophosphamide + Notes,Biochemistry,Biopsy,B DRUGS,CHARTS OF
DoxorubicinCarboplatin one marrow CHEMOTHERAPY
600mg/m2Etoposide studies,CBC,CECT/MRI,FISH REGIMEN,DISCHARGE
100mg/m2 (days ,MIBG OR BONE OR PET SUMMARY OF INPATIENT
5)CyclophosphamideDoxor CT SCAN DEPARTMENT /
ubicin DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
747 MO MO057 CT for Neuroblastoma Carboplatin + Cisplatin + MO057B MO057B1 S 8400 Y N Admission Or Clinical BAR CODE OF THE
Vincristine + Etoposide one marrow CHEMOTHERAPY
studies,CBC,CECT/MRI,FISH REGIMEN,DISCHARGE
,MIBG OR BONE OR PET SUMMARY OF INPATIENT
CT SCAN DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
748 MO MO057 CT for Neuroblastoma 13-cis retinoic acid MO057C MO057C1 S 2300 Y N Admission Or Clinical BAR CODE OF THE
160mg/m2 per day for 2 Notes,Biochemistry,CBC DRUGS,CHARTS OF
weeksEach cycle given 4 CHEMOTHERAPY
weekly REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
749 MO MO058 CT for Retinoblastoma Vincristine + Carboplatin + MO058A MO058A1 S 8200 Y N Admission Or Clinical BAR CODE OF THE
EtoposideCarboplatin Notes,Biochemistry,BONE DRUGS,CHARTS OF
600mg/m2 day 1Etoposide MARROW,CBC,CSF CHEMOTHERAPY
150mg/m2 1-3 STUDIES,MRI/CT (BRAIN REGIMEN,DISCHARGE
Vincristine1.5mg/m2 day 1 AND SUMMARY OF INPATIENT
ORBITS),ULTRASONOGRA DEPARTMENT /
PHY DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
750 MO MO059 CT for Rhabdomyosarcoma Vincristine + MO059A MO059A1 S 6300 Y N Admission Or Clinical BAR CODE OF THE
DactinomycinVincristine one marrow studies,BONE CHEMOTHERAPY
1.5mg/m2 (day 1, 8 and SCAN OR PET CT,CBC,MRI REGIMEN,DISCHARGE
15)Cyclophosphamie 1200 - OR CECT SUMMARY OF INPATIENT
2200 mg/m2 (day DEPARTMENT /
1)Dactinomycin 1.5mg / m2 DISCHARGE SUMMARY
(day 1)3 weekly cycle OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
751 MO MO059 CT for Rhabdomyosarcoma Vincristine + Ifosfamide + MO059B MO059B1 S 17900 Y N Admission Or Clinical BAR CODE OF THE
EtoposideVincristine Notes,Biochemistry,Biopsy,B DRUGS,CHARTS OF
1.5mg/m2 (days 1, 8 and one marrow studies,BONE CHEMOTHERAPY
15)Ifosfamide 1.8gm/m2 SCAN OR PET CT,CBC,MRI REGIMEN,DISCHARGE
(days 5)Etoposide OR CECT SUMMARY OF INPATIENT
100mg/m2 (days 5)Each DEPARTMENT /
cycle every 3 weeks DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
752 MO MO060 CT for Relapse Vincristine + Topotecan + MO060A MO060A1 S 13700 Y N 2D ECHO,Admission Or BAR CODE OF THE
Rhabdomyosarcoma Cyclophosphamide Clinical DRUGS,CHARTS OF
andVincristine + Adriamycin Notes,Biochemistry,Biopsy,B CHEMOTHERAPY
+ one marrow studies,BONE REGIMEN,DISCHARGE
CyclophosphamideVincristi SCAN OR PET CT,CBC,MRI SUMMARY OF INPATIENT
ne 1.5mg/m2 (day OR CECT DEPARTMENT /
1)Topotecan 1.5mg/m2 DISCHARGE SUMMARY
(day 5)Cyclophosphamide OF DAY CARE
250mg/m2 (days 5)3 - DEPARTMENT,REPORTS
weeklyVincristine OF THE TESTS
1.5mg/m2Adriamyicn (PATHOLOGY,
60mg/m2Cyclophosphamid RADIOLOGY,
e 600mg/m2 (all MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
753 MO MO061 CT for Wilms Tumor Vincristine + Actinomycin MO061A MO061A1 S 4200 Y N Admission Or Clinical BAR CODE OF THE
DVincristine 1.5 mg/m2 Notes,Biochemistry,Biopsy,C DRUGS,CHARTS OF
weekly for 12 weeks and BC,CT CHEST CHEMOTHERAPY
then 3 weeklyActinomycin D ABDOMEN,ULTRASONOGR REGIMEN,DISCHARGE
45 microgram / kg 3 weekly APHY SUMMARY OF INPATIENT
for 24 weeks DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
754 MO MO061 CT for Wilms Tumor Vincristine + Actinomycin D MO061B MO061B1 S 5500 Y N 2D ECHO,Admission Or BAR CODE OF THE
+ DoxorubicinVincristine 1.5 Clinical DRUGS,CHARTS OF
mg/m2 weekly for 12 weeks Notes,Biochemistry,Biopsy,C CHEMOTHERAPY
and then 3 BC,CT CHEST REGIMEN,DISCHARGE
weeklyActinomycin D 45 ABDOMEN,ULTRASONOGR SUMMARY OF INPATIENT
microgram/kg 3 APHY DEPARTMENT /
weeklyDoxorubicin DISCHARGE SUMMARY
60mg/m2 for 24 weeks OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
755 MO MO061 CT for Wilms Tumor Cyclophosphamide + MO061C MO061C1 S 16800 Y N 2D ECHO,Admission Or BAR CODE OF THE
Doxorubicin + Etoposide + Clinical DRUGS,CHARTS OF
Vincristine + Notes,Biochemistry,Biopsy,C CHEMOTHERAPY
DactinomycinVincristine 1.5 BC,CT CHEST REGIMEN,DISCHARGE
mg/m2Dactinomycin 45 ABDOMEN,ULTRASONOGR SUMMARY OF INPATIENT
microgram/kgAdriamyicn APHY DEPARTMENT /
60mg/m2Cyclophosphamid DISCHARGE SUMMARY
eEtoposideWeekly OF DAY CARE
chemotherapy - varying DEPARTMENT,REPORTS
hybrid regimen OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
756 MO MO062 CT for Pediatric Acute Consolidation (Phase II, MO062A MO062A1 S 263700 Y N Admission Or Clinical BAR CODE OF THE
Lymphoblastic Leukemia CNS Therapy Reinduction) Notes,Biochemistry,CBC DRUGS,CHARTS OF
CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
757 MO MO062 CT for Pediatric Acute India collaborative MO062B MO062B1 S 95700 Y N 2D ECHO,Admission Or BAR CODE OF THE
Lymphoblastic Leukemia childhood leukaemia group Clinical Notes,Biopsy,BONE DRUGS,CHARTS OF
Berlin- Frankfurt -Munster MARROW or Peripheral CHEMOTHERAPY
Kill acute lymphocytic blood FLOW REGIMEN,DISCHARGE
leukemia cells CYTOMETRY,CBC,CYTOGE SUMMARY OF INPATIENT
Mitroxantrone,Chlorambucil, NETICS,HBSAG,HCV,HIV,M DEPARTMENT /
Prednisolone: 841 DC,NCCT chest,PET-CT or DISCHARGE SUMMARY
CECT chest abdomen and OF DAY CARE
Pelvis(if LBL) DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
758 MO MO062 CT for Pediatric Acute 6 - Mercaptopurine MO062C MO062C1 S 3000 Y N Admission Or Clinical BAR CODE OF THE
Lymphoblastic Leukemia 75mg/m2 dailyMethotrexate Notes,Biochemistry,Biopsy,B DRUGS,CHARTS OF
20mg/m2 weeklyVincristine ONE MARROW,CBC,CSF CHEMOTHERAPY
1.5mg/m2 CYTOMORPHOLOGY,CYTO REGIMEN,DISCHARGE
monthlyIntrathecal GENETICS,FLOW SUMMARY OF INPATIENT
methotrexate 12 mg 3 CYTOMETRY,HBSAG,HCV, DEPARTMENT /
monthly HIV,MDC,NGS DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
759 MO MO062 CT for Ph+ve Pediatric Dasatinib + chemo (to be MO062D MO062D1 S 5500 Y N BONE MARROW or Clinical
Acute Lymphoblastic used only with ALL therapy)- Peripheral blood FLOW photograph,,Discharge
Leukemia for adult and Permonth CYTOMETRY,CBC,ECG,FIS Summary,Invoice / Receipt of
paediatric H,LFT,RFT,TUMOR BORD drugs and consumables
REPORT
760 MO MO062 CT for Ph+ve Pediatric Imatinib + chemo ((to be MO062E MO062E1 S 5500 Y N
Acute Lymphoblastic used only with ALL therapy)
Leukemia for adult and -permonth
paediatric
761 MO MO063 CT for Pediatric Consolidation (Phase II, MO063A MO063A1 S 263700 Y N Admission Or Clinical BAR CODE OF THE
Lymphoblastic Lymphoma CNS Therapy Reinduction) Notes,Biochemistry,CBC DRUGS,CHARTS OF
CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
762 MO MO063 CT for Pediatric India collaborative MO063B MO063B1 S 95700 Y N 2D ECHO,Admission Or BAR CODE OF THE
Lymphoblastic Lymphoma childhood leukaemia group Clinical Notes,Biopsy,BONE DRUGS,CHARTS OF
Berlin- Frankfurt -Munster MARROW or Peripheral CHEMOTHERAPY
Kill acute lymphocytic blood FLOW REGIMEN,DISCHARGE
leukemia CYTOMETRY,CBC,CYTOGE SUMMARY OF INPATIENT
cellsMitroxantrone,Chloram NETICS,HBSAG,HCV,HIV,M DEPARTMENT /
bucil,Prednisolone: 841 DC,NCCT chest,PET-CT or DISCHARGE SUMMARY
CECT chest abdomen and OF DAY CARE
Pelvis(if LBL) DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
763 MO MO063 CT for Pediatric 6 - Mercaptopurine MO063C MO063C1 S 3000 Y N Admission Or Clinical BAR CODE OF THE
Lymphoblastic Lymphoma 75mg/m2 dailyMethotrexate Notes,Biochemistry,Biopsy,B DRUGS,CHARTS OF
20mg/m2 weeklyVincristine ONE MARROW,CBC,CSF CHEMOTHERAPY
1.5mg/m2 CYTOMORPHOLOGY,CYTO REGIMEN,DISCHARGE
monthlyIntrathecal GENETICS,FLOW SUMMARY OF INPATIENT
methotrexate 12 mg 3 CYTOMETRY,HBSAG,HCV, DEPARTMENT /
monthly HIV,MDC,NGS DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
764 MO MO064 CT for Pediatric Acute Cytrabine 3 gram/m2 twice MO064A MO064A1 S 63400 Y N Admission Or Clinical BAR CODE OF THE
Myeloid Leukemia a dayDays 1, 3 and 5 Notes,Bone marrow DRUGS,CHARTS OF
aspiration,CBC,CYTOGENET CHEMOTHERAPY
ICS,flow cytometry or REGIMEN,DISCHARGE
Peripheral blood flow SUMMARY OF INPATIENT
cytometry,LFT,RBS,RFT DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
765 MO MO064 CT for Pediatric Acute Cytrabine 200mg/m2/day MO064B MO064B1 S 115800 Y N Admission Or Clinical BAR CODE OF THE
Myeloid Leukemia days 1-10 and Notes,Bone marrow DRUGS,CHARTS OF
Daunorubicin 50mg/m2 1, 3 aspiration,CBC,CYTOGENET CHEMOTHERAPY
and 5Etposide 100mg/m2 5 ICS,flow cytometry or REGIMEN,DISCHARGE
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
766 MO MO064 CT for Pediatric Acute Cytrabine 100- MO064C MO064C1 S 115400 Y N Admission Or Clinical BAR CODE OF THE
Myeloid Leukemia 200mg/m2/day days 1-7 Notes,Bone marrow DRUGS,CHARTS OF
and Daunorubicin 50mg/m2 aspiration,CBC,CYTOGENET CHEMOTHERAPY
1, 3 and 5 ICS,flow cytometry or REGIMEN,DISCHARGE
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
767 MO MO065 CT for Pediatric Acute Consolidation MO065A MO065A1 S 64700 Y N Admission Or Clinical BAR CODE OF THE
Promyelocytic Leukemia Notes,Biochemistry,BONEMA DRUGS,CHARTS OF
RROW,CBC,ECG,PML,RAR CHEMOTHERAPY
A,RQPCR REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
768 MO MO065 CT for Pediatric Acute Induction MO065B MO065B1 S 142400 Y N Admission Or Clinical BAR CODE OF THE
Promyelocytic Leukemia Notes,Biochemistry,CBC DRUGS,CHARTS OF
CHEMOTHERAPY
REGIMEN,DISCHARGE
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
769 MO MO065 CT for Pediatric Acute Maintenance (18 months MO065C MO065C1 S 43300 Y N 2D ECHO,Admission Or BAR CODE OF THE
Promyelocytic Leukemia total cost) Clinical DRUGS,CHARTS OF
Notes,APTT,Biochemistry,Bio CHEMOTHERAPY
psy,BONE MARROW FLOW REGIMEN,DISCHARGE
CYTOMETRY,CBC,CYTOGE SUMMARY OF INPATIENT
NETICS,FIBRINOGEN,HBSA DEPARTMENT /
G,HCV,HIV,MDC,NCCT DISCHARGE SUMMARY
chest,PML,PT,RARA,RQPCR OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
770 MO MO066 CT for Pediatric Hodgkins COPDAC: MO066A MO066A1 S 10400 Y N Admission Or Clinical BAR CODE OF THE
Lymphoma Cyclophosphamide, Notes,Biochemistry,Bone DRUGS,CHARTS OF
Vincristine marrow studies,CBC,node CHEMOTHERAPY
sulfate,Prednisone,Dacarba Biopsy,PET CT or CECT REGIMEN,DISCHARGE
zine Chest abdomen and pelvis SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
771 MO MO066 CT for Pediatric Hodgkins Oncovin,Etoposide,Prednis MO066B MO066B1 S 14300 Y N Admission Or Clinical BAR CODE OF THE
Lymphoma one,doxorubicin Notes,Biochemistry,Bone DRUGS,CHARTS OF
hydrochloride marrow studies,CBC,node CHEMOTHERAPY
Biopsy,PET CT or CECT REGIMEN,DISCHARGE
Chest abdomen and pelvis SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
772 MO MO067 CT for Pediatric Hodgkins ifosfamide, carboplatin, MO067A MO067A1 S 15400 Y N Admission Or Clinical BAR CODE OF THE
Lymphoma Relapse etoposide Notes,Biochemistry,Bone DRUGS,CHARTS OF
marrow studies,CBC,node CHEMOTHERAPY
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
773 MO MO067 CT for Pediatric Hodgkins DECA: MO067B MO067B1 S 15400 Y N Admission Or Clinical BAR CODE OF THE
Lymphoma Relapse Dexamethasone,Etoposide, Notes,Biochemistry,Bone DRUGS,CHARTS OF
Cytarabine,Cisplatin marrow studies,CBC,node CHEMOTHERAPY
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
774 MO MO067 CT for Pediatric Hodgkins IGVD: Need to check MO067C MO067C1 S 37400 Y N Admission Or Clinical BAR CODE OF THE
Lymphoma Relapse Notes,Biochemistry,Bone DRUGS,CHARTS OF
marrow studies,CBC,node CHEMOTHERAPY
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
775 MO MO068 CT for Pediatric Non Lymphoma malign B 89-96 MO068A MO068A1 S 46900 Y N 2D-ECHO,Admission Or BAR CODE OF THE
Hodgkins Lymphoma Consolidation (second Clinical DRUGS,CHARTS OF
month) Notes,Biochemistry,Biopsy or CHEMOTHERAPY
fluid flow cytometry,Bone REGIMEN,DISCHARGE
marrow SUMMARY OF INPATIENT
studies,CBC,ECG,PET CT or DEPARTMENT /
CECT Chest abdomen and DISCHARGE SUMMARY
pelvis OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
776 MO MO068 CT for Pediatric Non Lymphoma malign B 89-96 MO068B MO068B1 S 46700 Y N 2D-ECHO,Admission Or BAR CODE OF THE
Hodgkins Lymphoma Consolidation (First month) Clinical DRUGS,CHARTS OF
Notes,Biochemistry,Biopsy or CHEMOTHERAPY
pelvis OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
777 MO MO068 CT for Pediatric Non Lymphoma malign B 89-96 - MO068C MO068C1 S 72400 Y N 2D-ECHO,Admission Or BAR CODE OF THE
Hodgkins Lymphoma Maintenance Clinical DRUGS,CHARTS OF
pelvis OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
778 MO MO068 CT for Pediatric Non Mitroxantrone,Chlorambucil, MO068D MO068D1 S 108600 Y N 2D-ECHO,Admission Or BAR CODE OF THE
Hodgkins Lymphoma Prednisolone: 842 Clinical DRUGS,CHARTS OF
pelvis OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
BIOCHEMISTRY,ETC.)
779 MO MO069 PEDIATRIC-GCT/JEB PEDIATRIC-GCT/JEB MO069A MO069A1 S 11800 Y N Admission Or Clinical BAR CODE OF THE
Notes,AUDIOMETRY,Bioche DRUGS,CHARTS OF
mistry,Biopsy,CBC,CECT CHEMOTHERAPY
CHEST AND REGIMEN,DISCHARGE
ABDOMEN,GFR,TUMOR SUMMARY OF INPATIENT
MARKERS DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
780 MO MO070 CT for Pediatric Carboplatin + Cisplatin + MO070A MO070A1 S 6200 Y N 2D-ECHO,Admission Or BAR CODE OF THE
Hepatoblastoma Doxorubicin Clinical DRUGS,CHARTS OF
Notes,AUDIOMETRY,Bioche CHEMOTHERAPY
mistry,Biopsy,CBC,CECT REGIMEN,DISCHARGE
CHEST AND SUMMARY OF INPATIENT
ABDOMEN,ECG,GFR DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
781 MO MO070 CT for Pediatric Cisplatin MO070B MO070B1 S 6200 Y N Admission Or Clinical BAR CODE OF THE
Hepatoblastoma Notes,AUDIOMETRY,Bioche DRUGS,CHARTS OF
mistry,Biopsy,CBC,CECT CHEMOTHERAPY
CHEST AND REGIMEN,DISCHARGE
ABDOMEN,GFR,S. AFP SUMMARY OF INPATIENT
DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
DEPARTMENT,REPORTS
OF THE TESTS
(PATHOLOGY,
RADIOLOGY,
MICROBIOLOGY,
HEMATOLOGY,
NFUSION SLIPS
782 MO MO071 CT for CA Lung DocetaxelDocetaxel 75 MO071A MO071A1 S 9400 Y N Blood investigation reports Barcode of drugs used,BAR
mg/m2 D1 every 21 days such as CBC, LFT, RFT, CODE OF THE
abdomen and Pelvis,CECT CHEMOTHERAPY
Thorax, abdomen, pelvis REGIMEN,Charts of
reports,Chest x-ray report chemotherapy regimen &
,Clinical notes with transfusion
indications including stage, slips,DISCHARGE
signs, symptoms, relevant SUMMARY OF INPATIENT
history/ risk factors, planned l DEPARTMENT /
DISCHARGE SUMMARY
OF DAY CARE
783 MO MO071 CT for CA Lung ErlotinibErlotinib 150 mg MO071B MO071B1 S 5000 Y N Blood investigation reports Barcode of drugs used,BAR
once daily such as CBC, LFT, RFT, CODE OF THE
DISCHARGE SUMMARY
OF DAY CARE
784 MO MO071 CT for CA Lung GefitnibGefitinib 250 mg MO071C MO071C1 S 2800 Y N Blood investigation reports Barcode of drugs used,BAR
once daily such as CBC, LFT, RFT, CODE OF THE
DISCHARGE SUMMARY
OF DAY CARE
785 MO MO071 CT for CA Lung Paclitaxel + MO071D MO071D1 S 16000 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinPaclitaxel such as CBC, LFT, RFT, CODE OF THE
175mg/m2 D1Carboplatin RBS, LDH,Bronchoscopy (If DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days available),CBC,CECT CHEMOTHERAPY
reports,Chest x-ray report slips,DISCHARGE
indications including stage, DEPARTMENT /
signs, symptoms, relevant DISCHARGE SUMMARY
OF DAY CARE
radiology,
786 MO MO071 CT for CA Lung Pemetrexed + MO071E MO071E1 S 11200 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinPemetrexed such as CBC, LFT, RFT, CODE OF THE
500mg/m2 D1Carboplatin RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
AUC 5-6 D1 every 21 days abdomen and Pelvis,CECT CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
787 MO MO071 CT for CA Lung TopotecanTopotecan 1.5 MO071F MO071F1 S 27100 Y N Blood investigation reports Barcode of drugs used,BAR
mg/m2 D1-D5 every 21 such as CBC, LFT, RFT, CODE OF THE
days RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
DISCHARGE SUMMARY
OF DAY CARE
788 MO MO071 CT for CA Lung DocetaxelDocetaxel 20 MO071G MO071G1 S 3500 Y N Blood investigation reports Barcode of drugs used,BAR
mg/m2 D1 every week such as CBC, LFT, RFT, CODE OF THE
DISCHARGE SUMMARY
OF DAY CARE
789 MO MO071 CT for CA Lung Etoposide + MO071H MO071H1 S 8500 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinEtoposide such as CBC, LFT, RFT, CODE OF THE
100mg/m2 D1 - RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
D3Carboplatin AUC 5-6 D1 abdomen and Pelvis,CECT CHEMOTHERAPY
every 21 days Thorax, abdomen, pelvis REGIMEN,Charts of
DISCHARGE SUMMARY
OF DAY CARE
790 MO MO071 CT for CA Lung Etoposide + MO071I MO071I1 S 7500 Y N Blood investigation reports Barcode of drugs used,BAR
CisplatinEtoposide such as CBC, LFT, RFT, CODE OF THE
100mg/m2 D1 - D3Cisplatin RBS,Bronchoscopy (If DRUGS,CHARTS OF
75-100 mg/m2 D1 every 21 available),CBC,CECT CHEMOTHERAPY
hist OF DAY CARE
radiology,
791 MO MO071 CT for CA Lung GemcitabineGemcitabine MO071J MO071J1 S 9900 Y N Blood investigation reports Barcode of drugs used,BAR
1000mg /m2 D1 D8 every such as CBC, LFT, RFT, CODE OF THE
21 days RBS,Bronchoscopy (If DRUGS,CHARTS OF
available),CBC,CECT CHEMOTHERAPY
hist OF DAY CARE
radiology,
792 MO MO071 CT for CA Lung Gemcitabine + MO071K MO071K1 S 15300 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinGemcitabine such as CBC, LFT, RFT, CODE OF THE
1000 mg/m2 D1 RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
D8Carboplatin AUC 5-6 D1 abdomen and Pelvis,CECT CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
793 MO MO071 CT for CA Lung Gemcitabine + MO071L MO071L1 S 13400 Y N Blood investigation reports Barcode of drugs used,BAR
CisplatinGemcitabine 1000 such as CBC, LFT, RFT, CODE OF THE
mg/m2 D1 D8Cisplatin 75 RBS,Bronchoscopy (If DRUGS,CHARTS OF
mg/m2 D1 D8 every 21 available),CBC,CECT CHEMOTHERAPY
hist OF DAY CARE
radiology,
794 MO MO071 CT for CA Lung PaclitaxelPaclitaxel MO071M MO071M1 S 6600 Y N Blood investigation reports Barcode of drugs used,BAR
80mg/m2 every week such as CBC, LFT, RFT, CODE OF THE
DISCHARGE SUMMARY
OF DAY CARE
795 MO MO071 CT for CA Lung PaclitaxelPaclitaxel MO071N MO071N1 S 13000 Y N Blood investigation reports Barcode of drugs used,BAR
175mg/m2 every 21 days such as CBC, LFT, RFT, CODE OF THE
DISCHARGE SUMMARY
OF DAY CARE
796 MO MO071 CT for CA Lung Paclitaxel + MO071O MO071O1 S 8500 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinPaclitaxel such as CBC, LFT, RFT, CODE OF THE
50mg/m2 D1Carboplatin RBS, LDH,Bronchoscopy (If DRUGS,CHARTS OF
AUC 2 D1 every week available),CBC,CECT CHEMOTHERAPY
OF DAY CARE
radiology,
797 MO MO071 CT for CA Lung Paclitaxel + MO071P MO071P1 S 14700 Y N Blood investigation reports Barcode of drugs used,BAR
CisplatinPaclitaxel 175 such as CBC, LFT, RFT, CODE OF THE
mg/m2 D1Cisplatin RBS, LDH,Bronchoscopy (If DRUGS,CHARTS OF
75mg/m2 D1 every 21 days available),CBC,CECT CHEMOTHERAPY
OF DAY CARE
radiology,
798 MO MO071 CT for CA Lung Pemetrexed + MO071Q MO071Q1 S 10400 Y N Blood investigation reports Barcode of drugs used,BAR
CisplatinPemetrexed such as CBC, LFT, RFT, CODE OF THE
500mg/m2 D1Cisplatin 75 RBS, LDH,Bronchoscopy (If DRUGS,CHARTS OF
mg/m2 D1 every 21 days available),CBC,CECT CHEMOTHERAPY
OF DAY CARE
radiology,
799 MO MO071 CT for CA Lung PemetrexedPemetrexed MO071R MO071R1 S 8400 Y N Blood investigation reports Barcode of drugs used,BAR
500mg/m2 D1 every 21 such as CBC, LFT, RFT, CODE OF THE
days RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
DISCHARGE SUMMARY
OF DAY CARE
800 MO MO071 CT for CA Lung Vinorelbine + MO071S MO071S1 S 18700 Y N Blood investigation reports Barcode of drugs used,BAR
CarboplatinVinorelbine such as CBC, LFT, RFT, CODE OF THE
25mg/m2 D1 RBS,CBC,CECT Thorax, DRUGS,CHARTS OF
D8CarboplatinAUC 5-6 D1 abdomen and Pelvis,CECT CHEMOTHERAPY
DISCHARGE SUMMARY
OF DAY CARE
801 MO MO071 CT for CA Lung Vinorelbine + MO071T MO071T1 S 18700 Y N Blood investigation reports Barcode of drugs used,BAR
CisplatinVinorelbine such as CBC, LFT, RFT, CODE OF THE
25mg/m2 D1 D8Cisplatin RBS,Bronchoscopy (If DRUGS,CHARTS OF
75mg/m2 D1 every 21 days available),CBC,CECT CHEMOTHERAPY
hist OF DAY CARE
DEPARTMENT,Histopatholo
gy report,reports of the tests (
802 MO MO072 CT for CA Cervix Carboplatin Carboplatin MO072A MO072A1 S 3000 Y N Biochemistry reports Bar code of the drugs ,BAR
AUC 2 every week (RBS,LFT,RFT, Na, CODE OF THE
K),CBC,CBC ,CECT/MRI DRUGS,Charts of
Face and neck,Clinical notes chemotherapy regimen
with Details of pelvic ,CHARTS OF
examination (Per speculum CHEMOTHERAPY
and pervaginal examination), REGIMEN,DISCHARGE
,ECG ,ECHO,Histopathology DEPARTMENT /
report,histopathology - DISCHARGE SUMMARY
squamous carc OF DAY CARE
hema
803 MO MO073 CT for primary CNS De-Angelis/Methotrexate MO073A MO073A1 S 39600 Y N BONE MARROW BIOPSY Clinical
lymphoma ,Clinical notes,CT photograph,,Discharge
Scan,EXAMINATION Summary,Invoice / Receipt of
FINDINGS drugs and consumables
804 MO MO074 GCT Testis SA Carboplatin AUC 7 once MO074A MO074A1 S 6600 Y N Clinical notes,CT Clinical
every 3 weeks - Max 4 Scan,EXAMINATION photograph,,Discharge
cycles (price per cycle) FINDINGS,TUMOR Summary,Invoice / Receipt of
MARKERS drugs and consumables
805 MO MO075 CT for GCT of bone Denosumab Denosumab MO075A MO075A1 S 19800 Y N Clinical Clinical
120 mg s/c D1, 8, 15 then notes,CT/MRI,EXAMINATIO photograph,,Discharge
every 28 days- 19800 per N FINDINGS,X Ray Summary,Invoice / Receipt of
dose. Max 6 dose drugs and consumables
806 MO MO076 GEP NET Neuroendocrine Temozolamide 150mg/m2 MO076A MO076A1 S 8800 Y N All investigations reports Clinical
carcinoma D9-14 + Capecitabine including CBC,Biopsy,Clinical photograph,,Discharge
1gm/me D1-14 every 28 notes,EXAMINATION Summary,Invoice / Receipt of
days FINDINGS,Urine drugs and consumables
Routine,USG/CT/MRI report
807 MO MO076 GEP NET high grade Carboplatin AUC 5 + MO076B MO076B1 S 14800 Y N All investigations reports Clinical
Neuroendocrine carcinoma Etoposide 100mg/m2 D1- including CBC,Biopsy,Clinical photograph,,Discharge
D3 every 21 days notes,EXAMINATION Summary,Invoice / Receipt of
FINDINGS,Urine drugs and consumables
Routine,USG/CT/MRI report
808 MO SU060 Intravesical BCG / Induction cycles (PC)Rate SU060A SU060A1 S 3200 N N Clinical notes and Detailed discharge summary,
Mitomycin per dose -Rs 5000 max no- Histopathology/ biopsy Detailed Procedure /
06 (including drug) confirming the diagnosis of Operative Notes, original bills
bladder cancer of medicines administered
809 MO SU060 Intravesical BCG / Maintenance SU060B SU060B1 S 30000 Y N Clinical notes,Histopathology/ Detailed discharge
Mitomycin biopsy summary,Detailed Procedure
/ Operative Notes,original
bills of medicines
administered
1015 MR MR001 Linear Accelerator, External Radical MR001A MR001A1 M 23100 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy 3D line of treatment (documents (with RT treatment and doses
CRT (6 Fractions) confirming the Procedure given)
(Inclusive of Simulation & indicated and details of RT
Planning Cost) treatment plan),HPE report
1016 MR MR001 2D External Beam Adjuvant MR001B MR001B1 M 12100 Y N Clinical notes with planned Detailed Discahrge Summary
Radiotherapy (Telecobalt / line of treatment (documents (with RT treatment and doses
Strock LA) confirming the Procedure given)
(6 Fractions) indicated and details of RT
(Inclusive of Simulation & treatment plan),HPE report
Planning Cost)
1017 MR MR001 2D External Beam Neoadjuvant MR001C MR001C1 M 12100 Y N Clinical notes with planned Detailed Discahrge Summary
(Inclusive of Simulation &
1018 MR MR001 2D External Beam Additional fractions - 18 MR001D MR001D1 M 18900 Y N Clinical notes with planned Detailed Discahrge Summary
Radiotherapy (Telecobalt / Max upto (Every additional line of treatment (documents (with RT treatment and doses
Strock LA) fraction at Rs.500 per confirming the Procedure given)
(6 Fractions) Fraction) indicated and details of RT
Planning Cost)
1019 MR MR002 2D External Beam Palliative MR002A MR002A1 M 11000 Y N Clinical notes with Indications Detailed Discahrge Summary
Radiotherapy - Palliative (such as patient age, general (with RT treatment and doses
(Telecobalt / Strock LA) condition, staging, tumour given)
(Upto 10 Fractions) size, nodal status, presence
(Inclusive of Simulation & of enlarged internal
Planning Cost) mammary nodes at baseline,
Neoadjuvant CT received,
Margin status, pre-/ post-
surgery), planned line of
treatment (
1020 MR MR003 2D External Beam Radical MR003A MR003A1 M 22000 Y N Clinical notes with Indications Detailed Discahrge Summary
Radiotherapy (Telecobalt / (such as patient age, general (with RT treatment and doses
Strock LA) condition, staging, tumour given)
(25 Fractions) size, nodal status, presence
treatment (
1021 MR MR003 2D External Beam Adjuvant MR003B MR003B1 M 22000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
1022 MR MR003 2D External Beam Neoadjuvant MR003C MR003C1 M 22000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
1023 MR MR003 2D External Beam Additional fractions - 10 MR003D MR003D1 M 10500 Y N Clinical notes with planned Detailed Discahrge Summary
Radiotherapy (Telecobalt / Max upto (additional line of treatment (documents (with RT treatment and doses
Strock LA) fraction at Rs.500 per confirming the Procedure given)
(25 Fractions) Fraction upto a max) indicated and details of RT
Planning Cost)
1024 MR MR004 2D External Beam Radical MR004A MR004A1 M 21000 Y N Clinical notes with planned Detailed Discahrge Summary
Planning Cost)
1025 MR MR004 Linear Accelerator, External Adjuvant MR004B MR004B1 M 23100 Y N Clinical notes with Indications Detailed Discahrge Summary
Beam Radiotherapy 3D (such as patient age, general (with RT treatment and doses
CRT (6 Fractions) condition, staging, tumour given)
(Inclusive of Simulation & size, nodal status, presence
Planning Cost) of enlarged internal
mammary nodes at baseline,
treatment (
1026 MR MR004 Linear Accelerator, External Neoadjuvant MR004C MR004C1 M 23100 Y N Clinical notes with planned Detailed Discahrge Summary
1027 MR MR004 Linear Accelerator, External Additional fractions - 18 MR004D MR004D1 M 37800 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy 3D Max upto (Every additional line of treatment (documents (with RT treatment and doses
CRT (6 Fractions) fraction at Rs.1000 per confirming the Procedure given)
(Inclusive of Simulation & Fraction) indicated and details of RT
treatment (
1030 MR MR005 Linear Accelerator, External Neoadjuvant MR005C MR005C1 M 44000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
Beam Radiotherapy 3D Max upto (Every additional line of treatment (documents (with RT treatment and doses
CRT (25 Fractions) fraction at Rs.1000 per confirming the Procedure given)
(Inclusive of Simulation & Fraction) indicated and details of RT
Beam Radiotherapy IMRT line of treatment (documents (with RT treatment and doses
(Intensity Modulated confirming the Procedure given)
Radiotherapy) indicated and details of RT
(20 Fractions) treatment plan),HPE report
Planning Cost)
Beam Radiotherapy IMRT (such as patient age, general (with RT treatment and doses
(Intensity Modulated condition, staging, tumour given)
Radiotherapy) size, nodal status, presence
(20 Fractions) of enlarged internal
(Inclusive of Simulation & mammary nodes at baseline,
Planning Cost) Neoadjuvant CT received,
treatment (
1034 MR MR006 Linear Accelerator, External Neoadjuvant MR006C MR006C1 M 77000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
Beam Radiotherapy IMRT (Every additional fraction at line of treatment (documents (with RT treatment and doses
(Intensity Modulated Rs.2000 per Fraction) confirming the Procedure given)
Planning Cost)
Planning Cost)
treatment (
1038 MR MR007 Linear Accelerator, External Neoadjuvant MR007C MR007C1 M 46200 Y N Clinical notes with planned Detailed Discahrge Summary
Planning Cost)
Beam Radiotherapy IMRT Max upto (Every additional line of treatment (documents (with RT treatment and doses
(Intensity Modulated fraction at Rs.2000 per confirming the Procedure given)
Radiotherapy) Fraction) indicated and details of RT
Planning Cost)
1040 MR MR008 Linear Accelerator External Radical MR008A MR008A1 M 99000 Y N Clinical notes with Indications Detailed Discahrge Summary
Beam Radiotherapy IGRT (such as patient age, general (with RT treatment and doses
(Image Guided condition, staging, tumour given)
radiotherapy) with 3D CRT size, nodal status, presence
or IMRT of enlarged internal
(20 Fractions) mammary nodes at baseline,
(Inclusive of Simulation & Neoadjuvant CT received,
Planning Cost) Margin status, pre-/ post-
treatment (
1041 MR MR008 Linear Accelerator External Adjuvant MR008B MR008B1 M 99000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
1042 MR MR008 Linear Accelerator External Neoadjuvant MR008C MR008C1 M 99000 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
1043 MR MR008 Linear Accelerator External Additional fractions - 15 MR008D MR008D1 M 78800 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy IGRT Max upto(Every additional line of treatment (documents (with RT treatment and doses
(Image Guided fraction at Rs.2500 per confirming the Procedure given)
radiotherapy) with 3D CRT Fraction) indicated and details of RT
or IMRT treatment plan),HPE report
(20 Fractions)
Planning Cost)
1044 MR MR009 Linear Accelerator External Radical MR009A MR009A1 M 60500 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy IGRT line of treatment (documents (with RT treatment and doses
(Image Guided confirming the Procedure given)
radiotherapy) with 3D CRT indicated and details of RT
(6 Fractions)
Planning Cost)
1045 MR MR009 Linear Accelerator External Adjuvant MR009B MR009B1 M 60500 Y N Clinical notes with Indications Detailed Discahrge Summary
treatment (
1046 MR MR009 Linear Accelerator External Neoadjuvant MR009C MR009C1 M 60500 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy IGRT line of treatment (documents (with RT treatment and doses
(Image Guided confirming the Procedure given)
radiotherapy) with 3D CRT indicated and details of RT
(6 Fractions)
Planning Cost)
1047 MR MR009 Linear Accelerator External Additional fractions - 18 MR009D MR009D1 M 94500 Y N Clinical notes with planned Detailed Discahrge Summary
Beam Radiotherapy IGRT Max uptoEvery additional line of treatment (documents (with RT treatment and doses
(Image Guided fraction at Rs.2500 per confirming the Procedure given)
radiotherapy) with 3D CRT Fraction indicated and details of RT
(6 Fractions)
Planning Cost)
1048 MR MR010 SRT / SBRT with IGRT SRT / SBRT with IGRT MR010A MR010A1 M 90200 Y N Clinical notes with Indications Detailed Discahrge Summary
(Stereotacatic radiotherapy) (Stereotacatic radiotherapy) (such as patient age, general (with RT treatment and doses
(4 Fractions) condition, staging, tumour given)
treatment (
1049 MR MR010 SRT / SBRT with IGRT Additional fractions - 4Every MR010B MR010B1 M 92400 Y N Clinical notes with planned Detailed Discahrge Summary
(Stereotacatic radiotherapy) additional fraction at line of treatment (documents (with RT treatment and doses
(4 Fractions) Rs.11000 per Fraction confirming the Procedure given)
1050 MR MR011 SRS with IGRT SRS with IGRT MR011A MR011A1 M 77000 Y N Biopsy/ HPE report of Detailed Discahrge Summary
(Stereotacatic radiotherapy) (Stereotacatic radiotherapy) malignancy,Clinical notes (with RT treatment and doses
(Inclusive of Simulation & with Indications of SRS (such given)
Planning Cost) as patient age, general
condition, staging, tumour
size, nodal status, presence
of enlarged internal
Margin status, pre-/ pos
1051 MR MR012 Respiratory Gating along Respiratory Gating along MR012A MR012A1 M 71500 Y N Clinical notes and Detailed Discahrge Summary
with Linear Accelerator with Linear Accelerator Documentary evidence (with RT treatment and doses
planning (5 Fractions) planning confirming the need of given)
(Inclusive of Simulation & Respiratory-gated
Planning Cost) radiotherapy (tumours that
move with respiration during
radiotherapy (lung, breast
and upper abdominal
tumpurs),Clinical notes and
documentary evidence
confirming the need of
1052 MR MR012 Respiratory Gating along Additional fractions - 10 MR012B MR012B1 M 73500 Y N Clinical notes and Detailed Discahrge Summary
with Linear Accelerator Max uptoEvery additional Documentary evidence (with RT treatment and doses
planning (5 Fractions) fraction at Rs.3500 per confirming the need of given)
(Inclusive of Simulation & Fraction Respiratory-gated
Planning Cost) radiotherapy (tumours that
move with respiration during
radiotherapy (lung, breast
and upper abdominal
tumpurs)
1053 MR MR013 Brachytherapy High Dose Intracavitory MR013A MR013A1 M 3900 Y N Clinical notes with planned Detailed Discahrge Summary
Radiation (2D/X-ray) line of treatment (documents (with RT treatment and doses
(Maximum of 4 session) confirming the Procedure given)
indicated and details of RT
treatment plan),HPE report
1054 MR MR013 Brachytherapy High Dose Intraluminal MR013B MR013B1 M 3900 Y N Clinical notes with planned Detailed Discahrge Summary
1055 MR MR013 Brachytherapy High Dose Endobiliary MR013C MR013C1 M 3900 Y N Clinical notes with planned Detailed Discahrge Summary
1056 MR MR013 Brachytherapy High Dose Endobronchial MR013D MR013D1 M 3900 Y N Clinical notes with planned Detailed Discahrge Summary
1057 MR MR013 Brachytherapy High Dose CVS MR013E MR013E1 M 3900 Y N Clinical notes with planned Detailed Discahrge Summary
1058 MR MR014 Brachytherapy High Dose Interstitial / Intracavitary MR014A MR014A1 M 46200 Y N Clinical notes with Indications Detailed Discahrge Summary
Radiation (5 doses) complex planning like CT or (such as patient age, general (with RT treatment and doses
(Inclusive of Simulation, MR condition, staging, tumour given)
Planning Cost, OT & other size, nodal status, presence
charges ) of enlarged internal
treatment (
1059 MR MR014 Brachytherapy High Dose Surface Mould / MR014B MR014B1 M 46200 Y N Clinical notes with Indications Detailed Discahrge Summary
Radiation (5 doses) Intracavitary complex (such as patient age, general (with RT treatment and doses
(Inclusive of Simulation, planning like CT or MR condition, staging, tumour given)
Planning Cost, OT & other size, nodal status, presence
charges ) of enlarged internal
treatment (
1060 MR MR014 Brachytherapy High Dose Additional fractions - 11 MR014C MR014C1 M 39450 Y N Clinical notes with planned Detailed Discahrge Summary
Radiation (5 doses) line of treatment (documents (with RT treatment and doses
(Inclusive of Simulation, confirming the Procedure given)
Planning Cost, OT & other indicated and details of RT
charges ) treatment plan),HPE report
1061 MR MR015 iodine treatment 3 mCi large Dose scan/ Pre MR015A MR015A1 M 11400 Y N Biopsy/FNAC Biopsy/HPE,Radioiodine
Ablation - calculation of original treatment
treatment chart,THYROID SCAN
1062 MR MR015 iodine treatment 30 mCi Ablation of residual disease MR015B MR015B1 M 16900 Y N Biopsy/FNAC Biopsy/HPE,Radioiodine
any risk original treatment
chart,THYROID SCAN
1063 MR MR016 Iodine treatment 50 mCi Ablation of residual neck MR016A MR016A1 M 18000 Y N Biopsy/FNAC Biopsy/HPE,Radioiodine
disease low/intermediate original treatment
chart,THYROID SCAN
1064 MR MR020 Iodine treatment 250 mCi Ablation for metastatic MR020A MR020A1 M 40000 Y N Biopsy/FNAC Biopsy/HPE,Radioiodine
disease, High risk original treatment
chart,THYROID SCAN

Pmjay Himcare Oncology

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pmjay Himcare Oncology

Uploaded by

Copyright:

Available Formats

SL# Package Package PackageName PackageDescription PackageId- PackageID- IsMedSur Amount PreAuthS Government_

Category Category PMJAY HIMCARE gical tatus Reserved

515 MO MO001 CT for CA Breast Cyclophosphamide + MO001A MO001A2 S 7200 Y N

519 MO MO001 CT for CA Breast Cyclophosphamide + MO001D MO001D2 S 3900 Y N

520 MO MO001 CT for CA Breast Docetaxel + MO001E MO001E1 S 19800 Y N

521 MO MO001 CT for CA Breast Docetaxel + MO001E MO001E2 S 10200 Y N

You might also like